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Research Experience for Undergraduates 
University of Arkansas 
 
 
 The University of Arkansas Department of Chemistry and Biochemistry hosted a 
National Science Foundation sponsored Research Experience for Undergraduates (REU) summer 
program for the 20th year.  The department first hosted an REU in 1959.  The 10-week summer 
program, funded by the National Science Foundation, allowed students an opportunity to gain 
hands-on experience in a chosen research area while introducing them to careers in scientific 
research in areas including analytical chemistry and sensor technology, biochemistry and protein 
dynamics, inorganic chemistry and nanotechnology, organic chemistry, and physical and 
theoretical chemistry. 
 
 Undergraduate chemistry majors, who were sophomores or juniors in fall 2007, applied 
to the program, which took place in the Ozark Mountain Plateau. 
 
 Outside the lab, students met each week to hear presentations from campus experts about 
topics ranging from how to get into graduate school and test-taking skills to ethics, and how to 
make a poster presentation.  A number of social activities took place throughout the summer to 
give students a chance to interact. 
 
 Selected students received a scholarship to pay for room and board and an allowance to 
attend a regional or national chemical conference in the 2008-2009 academic year.  Students 
involved in the program were enrolled as students at the U of A and received one hour of 
research credit.  The program was conducted from May 18, 2008 to July 25, 2008. 
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Tony Jude Award
Kentucky native Nikita Patton, a student at Bennett College for Women, and Oregon 
native Ivy Fitzgerald, a student at Agnes Scott College, were the recipients of the Tony Jude 
Award for their summer research.  The Tony Judy Award recognizes a student or students for 
outstanding research.  It is awarded in memory of a former REU student who returned to the 
University of Arkansas and obtained a doctorate degree.
Nikita Patton, under the direction of Assistant Professor Paul Adams, presented a poster 
entitled “Preliminary Characterization of the Binding of Peptide Derivative of an Important 
RasGTPase Binding Effector for Abnormal Cell Signaling Mutants of the Ras Protein Cdc42.”  
Ivy Fitzgerald, under the direction of Assistant Professor T.K.S. Kumar, presented a 
poster entitled “Designing Fibroblast Growth Factor with Higher Heparin Binding Affinity.”
They are pictured below with Program Director Professor David Paul.
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REU Students 2008 
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Faculty Project List 
 
Paul Adams 
Assistant Professor 
Biophysical characterization of proteins associated with signal 
transduction 
Neil Allison 
Associate Professor and Vice-
Chair 
Organometallic chemistry, pentadienoyl chemistry, transition metal 
metallacycles 
Dan Davis 
Professor 
Photosynthesis, biophysics 
Bill Durham 
Professor and Chair 
Photochemistry of metal complexes, electron transfer reactions of 
metalloproteins 
Ingrid Fritsch 
Professor 
Miniaturized analytical devices, bioanalytical, electrochemistry, 
surface modification, microfluidics 
Bob Gawley 
Distinguished Professor 
Organic chemistry – dynamics, structure, and reactivity of  chiral 
organometallics, sensor design, dendrimers, natural products 
Roger Koeppe 
University Professor 
Membrane biophysics, voltage-dependent ion channels, design of 
membrane-spanning peptides, protein engineering and drug design 
T.K.S. Kumar 
Assistant Professor 
Protein 3-D structure, dynamics, folding and interactions 
Matt McIntosh 
Associate Professor 
Synthetic organic chemistry, natural products synthesis 
Frank Millett 
Distinguished Professor 
Biological electron transfer, cytochromes, biophysics 
David Paul 
Associate Professor 
Chemical sensors, instrumentation 
Xiaogang Peng 
Associate Professor 
Nano-technology, nano-crystalline materials 
Peter Pulay 
Distinguished Professor 
Ab initio methods, biophysics, parallel computing 
Josh Sakon 
Associate Professor 
Protein crystallography, biophysics 
Derek Sears 
University Professor 
Cosmochemistry 
Wesley Stites 
 Professor 
Protein chemistry, protein folding, biophysics 
Z. Ryan Tian 
Assistant Professor 
Hierarchical and ordered nanostructures for catalytic, sensing, and 
biomaterial applications 
Charles Wilkins 
Distinguished Professor 
Fourier transform nuclear magnetic resonance, infrared, and mass 
spectrometry, laboratory computer applications in chemical 
instrumentation, fundamentals of gas phase ion-molecule reactions, 
bioanalytical chemistry 
Jack Lay 
Director, Statewide Mass 
Spectrometry Facility 
Collaborates with other investigators that need mass spectrometry 
measurements and develops new methods for analysis of chemical 
and biologicals 
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UNIVERSITY OF ARKANSAS 
 NSF – CHEMISTRY – REU - SUMMER 2008 
Activities and Events 
Sunday, May 18 
2:00 p.m. – 4:00 p.m. Arrival, Check-In & Registration 
Maple Hill (front desk:  (479)718-2590 
 
6:00 p.m. – 9:00 p.m. Welcome Dinner 
University House, Penguin Ed’s Barbeque 
 
Monday, May 19 
8:00 a.m. – 8:45 a.m. Breakfast 
    Quad Dinning Room  
 
8:45 a.m.   Meet in quad lobby to go to university together 
 
9:00 a.m. – 10:00 a.m. Group Photo 
Front of Library 
 
10:00 a.m. – 12:00 p.m. Campus Logistics (Concurrent Sessions) 
 
RED  Session I:    10:00-10:50 a.m.    Session II:  11:00-11:50 a.m.   
YELLOW  Session II:   10:00-10:50 a.m.    Session I:   11:00-11:50 a.m.   
 
Session I:    Cash Checks, ID Cards Issued 
Arkansas Union  
Parking and Transit available:  $15 per parking tag. 
May park in lot 41 (near Reid Hall) Monday.  Tag 
needs to be displayed by Tuesday to avoid ticketing. 
Session II:   Library Orientation 
University of Arkansas Mullins Library 
 
 
12:00 p.m. - 1:30 p.m. Opening Luncheon 
    Place:  Student Union Ballroom 
Speaker:  Dr. Don Bobbitt, Dean, Fulbright College of Arts 
and Sciences 
 
1:30 p.m. – 2:30 p.m. Campus Tour (Ending at Union) 
 
2:30 p.m. – 4:30 p.m. Departmental Logistics, 
Place:  Chemistry Building 
Safety Briefing: Bill Durham, Department Chair 
    Meet your Mentor: Refreshments will be served 
    Get Keys, Take Photos 
Tuesday, May 20  Leadership/Team Building Activity (Includes Lunch) 
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9:00 a.m. – 3:00 p.m. Graduate Education Building Auditorium, Room 166 
Professor Ken Vickers 
Balance of day free for logistics.  Banking, Keys, etc. 
 
3:00 p.m. – 4:00 p.m. CHEMISTRY Library Tour 
 Place:  CHEM 225 
 Librarian:  Luti Salisbury 
 
Wednesday, May 21 Go to Your Lab and Get Started! 
8:00 a.m.    
 
5:30 p.m. – 7:00 p.m. Dinner & Dialogue 
    Place: Reynolds Center, Seminar Room A 
Speaker:  Dr. Collis Geren, Dean of the Graduate School & 
Vice Provost for Research 
Topic: “Little Brown Spider” 
 
Friday, May 23  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Dr. Don Bobbitt, Dean of the College of Arts & 
Sciences 
    Topic:  Ethics 
 
Saturday, May 24 – Monday May 26   Free for Memorial Day Weekend 
 
Wednesday, May 28 Dinner & Dialogue 
5:30 p.m. – 7:00 p.m. Place:  Reynolds Center, Seminar Room A 
    Speaker:  Panel of former REU students 
Topic:  Question/Answer session 
     
Friday, May 30  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Dr. Paul Adams 
Title:  “New Strategies to Prevent Degradation of 
Recombinant Proteins” 
     
Wednesday, June 4 Dinner & Dialogue 
5:30 p.m. – 7:00 p.m. Place:  Reynolds Center, Seminar Room A 
    Speaker:  Dr. Robert Brady, Chair, Dept. of 
Communications 
    Topic:  Presentation Skills 
 
Thursday, June 5  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host: Chemistry 
 
Friday, June 6  REU Meeting 
7 
 
1:00 p.m.   CHEM 105 
    Speaker:  Dr. Lothar Schäfer 
    Title:  “In Search of Divine Reality” 
      
 
Wednesday, June 11 Dinner & Dialogue 
5:30 p.m. – 7:00 p.m. Place:  Reynolds Center, Seminar Room A 
    Speaker:  Dr. Dennis Brewer, Assoc. Vice Provost, Grad. 
School 
Topic:  Research and Ethics 
 
Thursday, June 12  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host:  Physics 
    Location:   
 
Friday, June 13  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Dr. Julie Stenken 
Title:  “Microdialysis Sampling of Proteins Involved with 
Chemical Communication” 
 
Monday, June 16  Canoe Trip 
 
Wednesday, June 18 Dinner & Dialogue 
5:30 p.m. – 7:00 p.m. Place:   Reynolds Center, Seminar Room A 
    Speaker:  Shani Farr, Graduate Recruiter 
    Topic:  Applying to Graduate School      
     
Thursday, June 19  Evening Entertainment 
6:00 p.m. – 9:00 p.m. Host:  microEP 
    Location:  Veteran’s Park, Lake Fayetteville 
     
Friday, June 20  REU Meeting 
1:00 p.m.   CHEM 105 
Half-way Progress Reports Due 
 
Saturday, June 21  Practice GRE and GMAT test offered 
10 a.m.   Testing is FREE  
    Participation requires pre-registration  
    Location:  Bell Engineering, Room TBA 
 
Thursday, June 26  Evening Entertainment 
6:00 p.m.- 9:00 p.m. Host:  Mechanical Engineering 
    Location: 
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Friday, June 27  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Liz Williams 
    Topic:  Applying to Chemistry Graduate School 
 
Thursday, July 3  Evening Entertainment 
6:00 p.m.- 9:00 p.m. Host:  Carver 
    Location:   
 
 
Friday, July 4 – Sunday, July 6   Free for Independence Day Weekend 
    You must return to Fayetteville by 8:00 a.m., July 7 
 
Monday, July 7- 8   Road Trip, National Lab 
1.5 Days    
      
Wednesday, July 9 Final Carver Presentations 
3:00p.m. – 7:00 p.m.   
 
Friday, July 11  REU Meeting 
1:00 p.m.   Chem 105 
How to Make a Poster 
    Jennifer Sims, Editor, Chemistry and Biochemistry  
     
Friday, July 18  REU Meeting 
1:00 p.m.   CHEM 105 
    Speaker:  Dr. Bob Gawley  
Title:  “Why did Alice say to Kitty:  Do you Suppose Looking 
Glass Milk is Good to Drink?”    
 
Thursday, July 24  Meeting in Miniature, Lunch Served 
10:00 a.m.      CHEM 105 
  
Friday,  July 25  End of Program 
5:00 p.m.    Final reports due   
Dorm check-out 
 
Saturday, July 26  End of Program 
By 11:00 a.m.   Get out of the Dorm, last check-out 
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Designing Fibroblast Growth Factor with Higher Heparin Binding Affinity 
Ivy Fitzgerald, Agnes Scott College 
Decatur, Georgia 
 
 
Abstract 
 
Fibroblast Growth Factors (FGFs) belong to a large family of β-trefoil polypeptide growth 
factors involved in various important biological processes such as development and 
maintenance of cells. Proteoglycans, such as heparin, are required for the cell proliferation 
activities of FGFs. The three-dimensional structure of the FGF-heparin complex shows that 
the sulfate groups in the proteoglycans contribute significantly to binding. In the present 
study, we used a site-directed mutagenesis approach to design FGF with increased heparin 
binding affinity. Several residues in the heparin-binding loop of human acidic fibroblast 
growth factor (hFGF-1) were replaced with lysine residues. The effects of the mutations on 
heparin binding affinity and thermodynamic stability were assessed.  
 
Introduction 
 
Fibroblast growth factors (FGFs) play significant roles in the regulation of cell 
proliferation, angiogenesis, differentiation, tumor formation, embryonic growth, invasion, 
inflammation, and tissue repair.1,2  FGFs are also able to improve wound healing caused by 
metabolic diseases such as obesity, diabetes, infection, chronic liver failure, malnutrition, and 
second-degree burns.  To date, at least 23 FGFs have been discovered, named consecutively 
FGF-1 to FGF-23. FGFs are about 154 amino acids long and are believed to share a common 
core of 140 amino acids, of which 28 residues are highly conserved and 6 residues are invariant.3   
FGFs are all beta-barrel proteins and contain no disulfide bonds.  Studies have indicated that 
FGFs produce biological responses by binding to two types of receptors on the cell surface.2,4-5  
The first class is a high-affinity family of transmembrane tyrosine kinase receptors called 
FGFRs. The second class of receptors is the family of heparan sulfate proteoglycans (HSPGs), 
which have a low affinity for FGFs.6  The macromolecular interactions of the growth factors, 
HSPGs, and FGFR that lead to signal transduction are key to signaling by this important class of 
molecules.7 
 
The binding of FGFs to FGFRs plays an essential role in the biological activation of 
FGFs.8  Four FGFRs have been identified in humans and are well conserved throughout 
evolution.9  Alternate splicing results in binding specificity for the various members of the FGF 
family.10  Of the known FGFs, only FGF-1 and FGF-2 are universal ligands and can bind to all 
FGFRs.8  The prototype FGFR structure consists of an extracellular region, a transmembrane 
helix domain, and an intracellular tyrosine kinase domain. The common extracellular ligand-
binding domain is comprised of three immunoglobulin-like (Ig-like) domains - D1, D2, and D3 - 
each of which contains a disulfide bridge.12 Studies have shown that the interaction of FGFs with 
domains D2-D3 is a minimum requirement for sufficient ligand binding.13  Binding of FGF to 
FGFR leads to receptor dimerization and subsequent tyrosine autophosphorylation and 
phosphorylation of target molecules, which initiates a phosphorylation cascade within the cell 
that culminates in multiple cellular outcomes.14  
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Crucial for the dimerization of the tyrosine kinases are heparan sulfate proteoglycans.15,16  
HSPGs are polymers of disaccharide repeats, which are mostly highly sulfated and negatively 
charged.18  HSPGs are found in the extracellular matrix adjacent to cell surfaces and as integral 
components of the plasma membrane.19 Several different mechanisms have been proposed for 
the role of heparin in the mitogenic activity of FGFs and formation of the FGF-FGFR complex.  
The absence of HSPGs on the cell surfaces reduces FGF oligomerization, which affects FGF 
binding to FGFR(s) and lowers FGFR activity for cell proliferation.20  The interaction of heparin 
with FGFs stabilizes the protein against thermal denaturation, proteolysis, FGF release into 
interstitial spaces and limits diffusion.21  Binding also increases mitogenesis, wound healing, and 
neuro-vascularization.22  Additionally, heparin helps to increase the affinity and half-life of the 
FGF-FGFR complex, which is crucial for signal transduction.23  Residues involved in heparin 
binding correspond to amino acid 126 to 142 of the human FGF-1 sequence. In this context, we 
examined the role of additional lysine residues in the putative heparin-binding region of wild-
type FGF-1, as introduced by single and double -site mutagenesis on binding, stability, and 
structure using various biophysical techniques including multi-dimensional NMR spectroscopy. 
The results clearly indicate that the introduction of lysine residues in positions N128, Y139, and 
Q141 in the heparin-binding pocket significantly increases binding to sucrose octasulfate (SOS, a 
heparin analog) and conformational stability. In addition, results of this study provide a valuable 
basis for novel therapeutics targeting this interaction.  
 
Experimental Procedure 
Materials: Taq DNA polymerase, NdeI, and XhoI enzymes were purchased from Promega. 
Escherichia coli [BL21(DE3)pLysS] and pET20b(+) were purchased from Novagen. Sucrose 
octasulfate (SOS) and heparin-Sepharose were obtained from Toronto Research Chemicals 
(Toronto, ON) and Amersham Biosciences, respectively. Labeled 15NH4Cl, and D2O were 
purchased from Cambridge Isotope Laboratories. Urea, guanidine hydrochloride, 
phenylmethylsulfonyl fluoride, TritonX-100, and beta-mercaptoethanol were obtained from 
Sigma Chemical Co. All other chemicals used in this study were of high-quality analytical grade.  
FGF-1 Expression: The FGF-1 gene was inserted between EcoRI and NdeI restriction sites of 
the pET18b plasmid of pLysS E coli.  Cultures were grown in LB medium (25g/L) in presence 
of ampilicin and chloramphenicol at 37°C.  Overnight pre-culture was grown from glycerol 
stock.  Large-scale cultures were induced with 1mM of IPTG once the optical density at 600 nm 
reached 0.6, then the cultures were allowed to grow for another 5 hours at 37°C and 165 rpm.  
The cultures were centrifuged and the pellet was resuspended in a 10 mM phosphate buffer 
containing ethylenediaminetetraacetic acid (EDTA), Triton, beta-mercaptoethanol, and 
phenylmethylsulphonyl fluoride (PMSF) at pH 7.2.   
 
Protein Purification:  The proteins were extracted from the resuspended bacteria by sonification 
and centrifugation; the proteins were over-expressed in the supernatant, which was loaded onto a 
heparin-Sepharose column.  The column was washed sequentially with 10 mM phosphate buffer 
containing 0 M NaCl, 0.8 M NaCl, 1.5 M NaCl, and 2.0 M NaCl. The proteins eluted in the 1.5-2 
M NaCl fractions.  SDS-PAGE was used to visualize the purity of the protein fractions.  The 
protein was desalted using 10 mM phosphate + 100 mM NaCl + 50 mM ammonium sulfate 
buffer (pH 7.2).  
11
Mutagenesis: Single amino acid mutations were introduced using a QuikChange site-directed 
mutagenesis kit.  The primers used were, for N128K: forward:  5’ - TTT GTT GGC CTC AAG 
AAG AAG GGG AGC TGC AAA CGC GGT – 3’; reverse: 5’ – ACC GCG TTT GCA GCT 
CCC CTT CTT CTT GAG GCC AAC AAA – 3’.  For T137K: forward:  5’ – CGC GGT CCT 
CGG AAA CAC TAT GGC CAG AAA GC – 3’; reverse:  5’ – GC TTT CTG GCC ATA 
GTG TTT CCG AGG ACC GCG – 3’.  For Y139K:  forward: 5’ – CGC GGT CCT CGG ACT 
CAC AAA GGC CAG AAA GCA ATC TTG - 3’; reverse:  5’ –CAA GAT TGC TTT CAG 
GCC TTT GTG AGT CCG AGG ACC GCG – 3’.  For Q141K: forward:  5’ - GGT CCT CGG 
ACT CAC TAT GGC AAG AAA GCA ATC TTG TTT CTC CCC – 3’; reverse: 5’ – GGG
GAG AAA CAA GAT TGC TTT CTT GCC ATA GTG AGT CCG AGG ACC – 3’.  The 
underlined bases represent the base changes from the WT sequence.
The double mutation was introduced by creating an insert using PCR, using the N128K 
plasmid as a template, T7 promoter forward primer, and a reverse primer that introduced a 
mutation at the 139 position, or mutations at the 139 and the 141 positions.  The insert was 
ligated into the pET20b plasmid vector using the NdeI and EcoRI restriction sites.  The primer 
for the N128K/139K mutation was 5'- CGA ATT CGG ATC TCT TTC ATC AGA AGA GAC 
TGG CAG GGG GAG AAA CAA GAT TGC TTT CTG GCC TTT GTG AGT CCG AGG ACC 
GCG -3'.  The primer for the N128K/139K/Q141K mutation was 5'- CGA ATT CGG ATC TCT 
TTC ATC AGA AGA GAC TGG CAG GGG GAG AAA CAA GAT TGC TTT CTT GCC TTT
GTG AGT CCG AGG ACC GCG -3'.  The underlined bases represent the base changes from the 
WT sequence.
Steady-State Fluorescence: Urea denaturation, guanidine hydrochloride denaturation, and 
thermal denaturation were measured using a Hitachi F-2500 Fluorescence spectrophotometer.  
Fluorescence was measured at 308 nm and 350 nm.  Thermal denaturation was conducted from 
9-84°C at 2-3°C intervals.  Temperature was maintained using a circulating water bath.  Urea 
denaturation was conducted over the range 0.0 – 6.0 M urea at 0.2 M increments.  Guanidine 
hydrochloride denaturation was conducted over the range from 0.0 to 5.0 M, at 0.2 M 
increments.  6.0 M urea or 5.0 M GdnHCl was used to achieve the correct molarity; samples 
were brought to volume using a 10 mM phosphate, 100 mM NaCl, 50 mM ammonium sulfate 
buffer (pH 7.2).  Concentration of protein used was 20 µM. The urea, GdnHCl, and thermal 
denaturation experiments were performed in presence and absence of SOS. 
Proteolytic Digestion Assay: The limited proteolytic experiments on FGF-1 and the FGF-1-SOS 
mixture (1:1) were carried out (at 37 ± 2 C) using trypsin. Proteolytic digestions were 
performed at an enzyme (trypsin)/substrate (FGF-1) molar ratio of 1:10. The protease activity 
was stopped after a desired time interval by the addition tricholoroacetic acid and placement on 
ice.  The degree of proteolytic cleavage was measured from the intensity of the ~16-kDa band on 
a SDS-PAGE gel using a densitometer. The intensity of the ~16-kDa band corresponding to 
FGF-1 not subjected to protease treatment was considered the control for 100% protection 
against trypsin cleavage.  
Differential Scanning Calorimetry: Thermal-induced unfolding was performed in a Nano III 
DSC (Calorimetry Sciences Corp.) fitted with a capillary cell. All of the samples were degassed 
for 2 min at room temperature prior to loading. The scan rates was 1°C/min. Thermograms of 
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proteins (0.5 mg/mL) alone and in the presence of SOS/heparin were obtained from 10 to 80 °C
using a scan rate of 1°C/min. The filled cells were equilibrated for 10 min at 10°C before the 
beginning of each scan. Before each experiment, buffer blank experiments were run to obtain a 
stable baseline. Thermograms of the buffer alone were subtracted from each protein scan prior to 
analysis using software supplied by Calorimetry Sciences Corp.
Isothermal Calorimetry: Binding of SOS/heparin to FGF-1 was analyzed by measuring the heat 
change during the titration the protein solution with of SOS/heparin using a VP-ITC titration 
microcalorimeter (MicroCal, Inc., Northampton, MA).  All protein and ligand (SOS/heparin) 
solutions were degassed under vacuum and equilibrated at 25 C prior to titration. The sample 
cell (1.4 mL) contained 0.04 mM FGF-1 dissolved in 10 mM phosphate buffer (pH 7.2) 
containing 100 mM NaCl and 50 mM ammonium sulfate. The reference cell contained water. 
Upon equilibration, 0.5 to 0.6 mM SOS/heparin was injected in 47 × 6 µL aliquots using the 
default injection rate of 300 s intervals between each injection to allow the sample to return to 
the baseline. The resulting titration curves were corrected with the protein-free buffer control and 
analyzed using the software supplied by Microcal, Inc. 
NMR Experiments: All NMR experiments were performed on a Bruker Avance-700 MHz NMR 
spectrometer equipped with a cryoprobe at 25 C. 15N decoupling during acquisition was 
accomplished using the globally optimized altering-phase rectangular pulse sequence. Spectra 
were acquired with 8 transients of 1024 data points and 64 t1 increments. The HSQC spectra 
were recorded at 32 scans at all concentrations of SOS. The concentration of the protein sample 
was 0.5 mM in 95% H2O and 5% D2O [10 mM phos (pH 7.2)] containing 100 mM NaCl and 50 
mM AMS. All of the spectra were processed on a Windows workstation using XWIN-NMR and 
Sparky softwares.24
Results and Discussion
Human FGF-1 has 12 beta-strands arranged into a beta-trefoil motif. A dense cluster of 
positively charged residues located in the loop between beta-strands 10 and 11 constitutes the 
heparin-binding site (Figure 1). In this study, neutral and negatively charged amino acids in the 
in the putative sugar-binding region were changed to the basic amino acid lysine.  Specifically, 
mutations were created in positions N128, Y139, and Q141 (Figure 1). Binding affinity 
experiments were carried out with heparin and sucrose octasulfate (SOS).  SOS is a polysulfated 
heparin analog commonly used as a structural and functional mimic for heparin. The chemical 
structure of SOS with its eight sulfate residues resembles the repeating disaccharide units of 
heparin.  SOS has also been widely used as an antiulcer drug and has been shown to accelerate 
ulcer healing without reducing gastric acids.28
SOS binding to hFGF-1. Isothermal titration calorimetry (ITC) is a versatile technique used to 
characterize protein-protein or protein-ligand interactions.25 ITC experiments provide direct 
information about the stoichiometry, affinity, and enthalpy of protein-ligand binding reactions.24
The binding isotherm characterizing SOS/heparin-hFGF-1 interaction is nearly sigmoidal (Figure 
2). The interaction proceeds with the evolution of heat with negative enthalpy, suggesting that 
electrostatic interactions play a predominant role in the protein/SOS interactions. The binding 
isotherm best fits a one-site binding model yielding binding constant values of 2.237 x10-5 M for 
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SOS and 5.128 x10-6 M for heparin.  These results of show that hFGF-1 interacts with 
SOS/heparin and that one molecule of the protein appears to bind one molecule of SOS/heparin. 
The binding affinity shared by SOS and hFGF-1 was re-examined in three different single-point 
mutants (N128K, Y139K, and Q141K) and in a double point mutant (N128K/Y139K) (Figure 2).  
All three single point mutants showed 10-fold increase in their binding affinity to SOS (~10-6 
M); moreover, the double mutant showed significant increase (~100-fold) both in SOS and 
heparin binding affinity (~10-7 M) compared to the wild type hFGF-1 (Figure 2). Table 1 
provides a summary of the thermodynamic data for the all of the ITC experiments. The ITC data 
clearly suggests that the lysine mutants of hFGF-1 are indeed in biologically active conformation 
and binds to SOS more strongly than the wild type.  
 
hFGF-1 mutants are stabilized by SOS/heparin binding. Differential Scanning Calorimetry 
(DSC) is a thermo-analytical technique in which the difference in the amount of heat required to 
increase the temperature of a sample and reference are measured as a function of temperature.26 
Both the sample and reference are kept at the same temperature throughout the experiment. In 
this context, we performed thermal denaturation of hFGF-1-wild type, three single-point mutants 
(N128K, Y139K, and Q141K) and the double mutant (N128K/Y139K) in absence and in 
presence of SOS/heparin (Figure. 3). The data shown in Figure 3 was corrected for a linear 
native baseline. There is an increase in the midpoint transition temperature from ~51.5°C for 
hFGF-1-WT alone to Tm ~63.5°C in the presence of SOS and 67.1 °C in the presence of heparin. 
The Tm difference between the WT without and with ligand was ~ 12. 5°C for SOS and ~15.6°C 
for heparin. All the single point mutants (N128K, Y139K, and Q141K) showed a slight increase 
in the difference in transition temperature- around ~12.9°C in the presence of SOS. However, the 
double mutant (N128K/Y139K) showed significant increase in the transition temperature, both in 
the presence of SOS and heparin (~14.2°C and 18.2°C, respectively) as compared to the wild 
type. The thermal transition of wild type, single, and double mutants of hFGF-1 are irreversible. 
Table 2 gives a summary of the transition temperatures.  
 
Stability monitored by fluorescence thermal denaturation.  The emission spectrum of native 
hFGF-1 is dominated by a tyrosine emission peak at 308 nm. In the completely unfolded state (in 
8 M urea), FGF-1 exhibits an emission spectrum that is dominated by a single well-conserved 
tryptophan at position 121,27 which fluoresces at 350 nm.  These spectral features are ideal for 
monitoring the denaturant-induced unfolding of the protein and also serve as an excellent probe 
for monitoring the tertiary structural changes that occur in the protein under different conditions. 
Equilibrium thermal denaturation of wild type and the N128K/Y139K double mutant of hFGF-1 
were performed to assess the conformational stability of the protein upon binding with SOS 
(Figure 4A). The Tm (the temperature at which 50% of the molecules are in the native state) of 
the double mutant (N128K/Y139K) increased in the presence of the SOS by about 5.4°C (from 
44.7°C to 50.1°C). In contrast, the Tm of the double mutant increased in by about 11.2° C (from 
42.6 °C to 53.8°C), suggesting that thermodynamic stability of the double mutant is enhanced 
upon binding to the SOS as compared to the wild type.  
 
Stability monitored by Gdn-HCl/urea induced denaturation. Unfolding of wild type hFGF-1 
monitored by steady state fluorescence reveals that the wild type hFGF-1 is completely unfolded 
beyond 1.6 M guanidine hydrochloride (Figure 4B). The Cm (concentration of the denaturant at 
which 50% of the protein is unfolded) values of the unfolding curves for wild type hFGF-1 
14 
 
obtained in absence and in presence of SOS are 1.25 M and 1.75 M, respectively. Unfolding of 
N128K/Y139K double mutant is completely unfolded beyond 1.4 M GdnHCl (Figure 3B), but in 
contrast to wild type, the Cm values of the double mutant obtained in absence and in presence of 
SOS are 1.05 M and 1.85, respectively. Additionally, urea-induced unfolding of wild type and 
double mutant was investigated to determine whether the stability is dependent on the nature of 
the denaturant. The Cm values of the unfolding curves for wild type hFGF-1 obtained in absence 
and in presence of SOS are 2.38 M and 3.40 M, respectively (Figure 4C), but in contrast to the 
wild type the Cm values of the double mutant obtained in absence and in presence of SOS are 
2.40 M and 3.75 M, respectively. All the above stability experiments suggest that 
thermodynamic stability of the double mutant is enhanced upon binding to SOS.  
 
Proteolytic digestion. Limited proteolytic digestion is a popular technique used to probe the 
protein-ligand interactions.29 Proteolytic digestion, in general, is governed not only by 
stereochemistry and accessibility of the protein substrate but also by the specificity of the 
proteolytic enzyme.  In principle, binding of a ligand/drug can potentially mask the cleavage 
sites in the protein substrate, and these subtle differences in the cleavage patterns (between the 
free and the ligand/drug-bound protein substrate) could be easily detected by SDS-PAGE 
analysis. Because hFGF-1 is rich in arginine and lysine residues, we performed limited trypsin 
digestion to probe the binding of SOS to wild type and N128K/Y139K double mutant of hFGF-
1. Time-dependent trypsin digestion of the proteins in the free and SOS-bound forms was 
monitored by SDS-PAGE analysis using Coomassie Blue staining. The degree of digestion was 
measured based on the intensity of the undigested hFGF-1 ~16-kDa band.  The tryptic digests of 
wild type hFGF-1, obtained in the presence and absence of SOS, clearly revealed that the protein 
bound to SOS has increased resistance to proteolytic cleavage (Figure 5A). The enhanced 
resistance to trypsin cleavage could be due to masking of some of the potential enzyme cleavage 
sites in hFGF-1 by SOS. The N128K/Y139K double mutant trypsin digestion showed more 
resistance than the wild type in the presence of SOS.  Densitometric scans of the undigested 
hFGF-1 band obtained after various time periods of incubation of the protein with trypsin, show 
that the double mutant is stabilized more than the wild type in the presence of SOS. More than 
92% of the ~16 kDa double mutant of hFGF-1 band remains intact in the presence of SOS after 
180 min (Figure 5B). These results clearly indicate that SOS binds to the double mutant of 
hFGF-1 with high-affinity and sterically restricts the exposure of the trypsin cleavage sites in the 
SOS-binding site.  
 
Identification of SOS binding site(s) on hFGF-1.  NMR spectroscopy is a versatile technique to 
map the protein-drug interface with atomic resolution and also to measure the binding affinity 
and stoichiometry of protein-ligand interactions.25 The 1H-15N HSQC spectrum is a fingerprint of 
the conformational state(s) of the protein. Each cross-peak in the spectrum represents an amino 
acid in a particular conformational state of the protein. Therefore, the conformational changes 
and ligand-binding site(s) in a protein can be conveniently identified by the chemical-shift 
perturbation/disappearance of cross-peaks in the 1H-15N HSQC spectrum. The overlapped 
spectra of the wild type and N128K/Y139K double mutant shows that most of the cross-peaks 
from wild type are retained, except for the residues that are mutated and those adjacent to the 
mutated residues (Figure 6A). The data shows that the backbone conformation of the double 
mutant is very similar to that of wild type.  1H-15N HSQC spectra of wild type hFGF-1 acquired 
at various hFGF-1/SOS ratios revealed that only a few cross-peaks were perturbed from their 
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original positions in the native-state spectrum (Figure 6B). The residues that exhibit 
prominent 1H-15N chemical-shift perturbations are located in stand XI and the loops between 
strands X and XI and strands XI and XII (Figure 6C).  
 
Conclusion 
 
The results obtained in this study clearly show that the incorporation of additional lysine residues 
significantly increases the heparin/SOS binding affinity. In addition, the thermodynamic stability 
of the mutant forms of hFGF-1 is also significantly enhanced upon binding to SOS. We also 
demonstrated that the conformation of the hFGF-1 is not significantly perturbed.   Work is in 
progress to investigate the mitogenic activity of the various designed mutants of hFGF-1.  
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Figure Legends 
 
Figure 1. MolMol representation of hFGF-1.  The heparin-binding region is mostly located in 
beta strand XI, the loop between strands X and XI and the loop between strands XI and XII, 
which is in the tip right section of the figure.  The three amino acids mutated in this study are 
shown.  
 
Figure 2. ITC curves showing the binding of SOS/heparin to wild type and mutants of hFGF-1 
at 25 °C. The upper panels show the raw data representing hFGF-1 – SOS titration. The bottom 
panels show the integrated data obtained from the raw data after background subtraction. The 
solid line in the bottom panels represents the best-fit curve of the experimental data, using the 
one site and sequential binding site(s) model from Microcal Origin.  
 
Figure 3. Differential scanning calorimetry thermograms representing the unfolding of wild type 
and mutants of hFGF-1. The protein (0.5 mg/mL) was dissolved in 10 mM phosphate buffer (pH 
7.2) containing 100 mM NaCl and 50 mM ammonium sulfate. Thermograms were corrected for 
background noise. The experiments were performed at a scan rate of 1°C/min. 
 
Figure 4.  Panels A, B, and C represent the equilibrium unfolding of the wild type hFGF-1 and 
the N128K/Y139K double mutant of hFGF-1 in absence and presence of SOS, induced by 
thermal, guanidine hydrochloride, and urea, respectively. The denaturation were monitored by 
steady-state fluorescence at 350 nm. The binding of SOS provides additional stability to the 
double mutant as compared to the wild type hFGF-1.  
 
Figure 5. Time-dependent trypsin digestion of the wild type and N128K/Y139K double mutant 
of hFGF-1 in absence and presence of SOS. Lanes 1 through 9 represent the trypsin digestion 
products formed after 0 min (lane 1), 15 min (lane 2), 30 min (lane 3), 45 min (lane 4), 60 min 
(lane 5), 90 min (lane 6), 120 min (lane 7), 150 min (lane 8) and 180 min (lane 9). Panel B 
represents the densitometry scan of the band corresponding to hFGF-1 wild type and the 
N128K/Y139K mutant band (~16 kDa). The concentration of the protein and SOS used were 
0.05 mM and 0.5 mM, respectively.  
 
Figure 6. Panel A- 1H-15N HSQC spectra of wild type hFGF-1 obtained in the absence (darker) 
and presence (lighter) of SOS. The significant chemical shift perturbation observed in the 
presence of SOS indicates that these residues are in the vicinity of the SOS site(s). Panel B- 
Overlap of the 1H-15N HSQC spectra of N128K/Y139K double mutant (lighter) and wild type 
hFGF-1 (darker). Panel C- 1H-15N chemical shift perturbation of residues in hFGF-1 in the 
presence of SOS. The amino acid residues in hFGF-1 that exhibited significant chemical shift 
perturbation and are involved in SOS binding are indicated by the residue number. Panel D- 
MolMol representation of the structure of hFGF-1. Residues which exhibit prominent chemical-
shift perturbation are in the lighter section. The residues constituting the SOS binding site(s) are 
mostly located in beta strand XI and the loops between strands X and XI and strands XI and XII.  
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Table 1
Table 2
Table 2. Depicting the Tm Values from DSC
2.237x10-5FGF-1-WT Vs SOS
5.128x10-6FGF-1-WT Vs Heparin
2.785x10-7N128K/Y139K Vs Heparin
Kd1- 3.597x10-6
Kd2- 2.237x10-5
Kd3- 3.105x10-5
Q141 Vs SOS
9.708x10-7N128K/Y139K Vs SOS
Sample Kd
N128K  Vs SOS Kd1-6.535x10-5
Kd2-4.761x10-5
Kd3-2.475x10-4
Y139K Vs SOS 6.896x10-6
Table1. Depicting the binding constant (Kd) characterizing SOS-hFGF-1.
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Investigations of an Immunoassay-Compatible Species for  
Pumping with Magnetohydrodynamic Force 
Christena Hooten, University of Arkansas 
Fayetteville, Arkansas 
 
 
Abstract 
 
To use Magnetohydrodynamic flow to automate the building of a sandwich immunoassay 
containing alkaline phosphatase (AP), a compatible redox pumping species must be found.  
To be a suitable pumping species for this method, the species must undergo 
electrochemistry without perturbing the enzyme generated product, p-aminophenol (PAP).  
Through cyclic voltammetry, my research demonstrates the electrochemical compatibility 
of ruthenium (III) hexamine with PAP.  My research also shows solution flow using PAP 
itself as the pumping species at concentrations as low as 4 mM.   
 
Introduction 
 
 The demand for handheld devices in healthcare, food sciences, and environmental 
sciences has been the subject of recent research.  Electrochemical detection has been identified 
as a good way to produce small, affordable biosensors.  An immunoassay, which can be 
combined with electrochemical detection, uses the specific binding between an antigen and its 
antibody to measure the analyte (the antigen) concentration in complex matrixes5 (figure 1) and 
only requires nanoliter volutes of solution.1  Immunoassays have been built on multiple 
substrates including glass, silicon, and gold, giving it a wide variety of applications.3  One of the 
goals of the lab-on-a-chip (LOAC) devices is to develop an automated method that combines 
injection and pumping of wash solutions and immunoassay components, with analytical 
detection processes4.  A different kind of LOAC application is to carry out compound synthesis 
and reagent-product separation.  The automation of such multi-step LOAC can only be carried 
out through the use of microfluidics.  There are several ways to perform microfluidic pumping 
and all of thos methods have different advantages and disadvantages.  The method investigated 
here, redox-magnetohydrodynamics (redox-MHD), is quite new, but may be very useful because 
it exhibits characteristics that complement the existing set of pumps.   To date there are only a 
few publications on redox-MHD,6,7 but the concentrations of redox species used to show an 
MHD effect are so high at the low magnetic fields used in portable devices that it puts into 
question the usability of this method for biochemical applications.  This paper resolves this 
question. 
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Figure 1 is a schematic of a sandwich immunoassay. 
 
MHD occurs when a net flux of ions (j) interacts with the perpendicular component of the 
magnetic flux density (B), creating a Lorentz force, FMHD in a third direction governed by the 
right hand rule, j x B = FMHD.  This force is sufficient to produce microfluidic pumping and the 
direction of flow can be reversed by reversing the polarity of an electrode (e.g. changing the 
potential from oxidizing to reducing values or visa versa) at which the ions are generated or used 
up.  The MHD pumping method described in this paper uses two working electrodes.  These 
electrodes are held at potentials of equal magnitude, but opposite sign. This creates circular flow 
around the working electrodes in opposite direction (figure 2).  Although the flows are opposite 
in direction, the flow combines coming down the middle of the array, and can increase the flow 
rate.   
 
Figure 2 illustrates reinforcing flow MHD. 
 
Magnetohydrodynamic flow is a way to manage solution flow without requiring highly 
skilled laboratory technique.  Antigen-antibody binding is limited by mass transport, not binding 
kinetics;2 therefore, the convection flow created by MHD will also decrease incubation times.  
To date, no research has been performed to find a redox pumping species that is compatible with 
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biochemical substances such as antibodies, enzymes (e.g. alkaline phosphatase, AP), enzyme 
substrates (e.g. p-aminophenylphosphate, PAPP), and enzyme-generated products (e.g. p-
aminophenol, PAP).  The most suitable choice for a redox pumping species should undergo 
electrochemistry at a different potential than that for enzyme substrate and should not react with 
any component of the immunoassay.  It is also highly desirable that the redox pumping species 
does not alter the composition of the enzyme generated product.  This paper reports two suitable 
redox species for MHD pumping and shows that fluid flow can be seen at low redox 
concentrations.    
 
Experimental Procedures 
 
Chemicals.  All chemicals were reagent grade and used as received.  Aqueous solutions were 
prepared using high-purity deionized (DI) water from Ricca.  The 0.1 M Tris buffer was 
prepared with 0.1M tris (hydoxymethyl)aminomethane from J. T. Baker, 1 mM magnesium 
chloride from Fisher Chemical, and 0.02% (w/v) sodium azide from Sigma and was adjusted to 
pH 9.0 with 6 M HCl.  Ruthenium (II) hexamine chloride, potassium ferrocyanide, and p-
aminophenol were obtained from Aldrich. 
 
Electrochemical Measurements.  A CH Instruments potentiostat was used to perform cyclic 
voltammetry (CV) on solutions containing redox species.  A three electrode setup containing a 
10 μm Au polished disk electrode from CH Instruments as the working electrode, a Pt flag 
electrode as the auxiliary electrode, and Ag/AgCl (saturated KCl) electrode as the reference 
electrode. 
 
MHD Methods.  A microband array was used to perform electrochemistry on a 4 mM solution 
of PAP.  A MHD reinforcing flow electrode configuration was used to create solution flow.  Two 
sets of three 50 μm bands were shorted together to make two working electrodes on opposite 
sides of the microband array.  One working electrode was held at a potential of +0.3 V.  The 
working electrode on the opposite side was held at a potential of -0.3 V.  A larger gold counter 
electrode and polarizable gold pseudoreference electrode, also fabricated on-chip, were used to 
complete the circuit.  Water containing 10 μm diameter polystyrene beads from Alpha Aesar was 
pipetted into the solution diluting the bead solution by 200 times.  With the aid of a microscope, 
the bead movement was observed and filmed.  Particle tracking software was used to measure 
the bead speed.  The procedure and setup is much like that used in our laboratory previously by 
Anderson et al.8 
 
Results and Discussion 
 
Finding a Suitable Redox Pumping Species.  A typical immunoassay involving 
electrochemical detection uses an alkaline phosphatase (AP) label conjugated to the secondary 
antibody to convert p-aminophenylphosphate (PAPP) to p-aminophenol (PAP).  It is the PAP 
which is elctroactive and undergoes a 2-electron oxidation to form a quinoneimine at the 
electrode, leading to the electrochemical signal.  The usual concentration of the PAPP enzyme 
substrate is 4 mM in a pH 9 Tris buffer in these kinds of heterogeneous sandwich assays.  The 
basic buffer allows the AP to be most active. 
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It is important that the redox pumping species not convert the PAPP directly to PAP, 
which would preclude the use of the electrochemical signal from PAP to quantify the assay.  In 
all of the studies with the species described below, we first confirmed that PAPP was 
undisturbed in the presence of the pumping redox species. 
 
Second, we determined whether the electrochemical behavior of the pumping species and 
PAP would be sufficiently compatible so that we could still be able to quantify the amount of 
PAP in the solution.  Details of these latter experiments are shown below.  The maximum signal 
that an assay would be able to provide for a 4 mM PAPP solution would be one be one where 
complete enzymatic conversion to PAP (4 mM) occurs.  Thus, in the experiments described in 
this section, a 4 mM concentration of PAP was used. 
 
The first redox pumping species that was investigated was 6 mM potassium ferrocyanide 
in 0.1 M Tris.  We originally selected ferrocyanide, because in previous studies in our laboratory, 
the E˚ value was more negative of that of PAP in our supporting KCl electrolyte.  However, in 
the basic pH Tris buffer, the E° value of ferrocyanide shifted to a value that was at such a 
positive potential that its oxidation was indistinguishable from the oxidation of PAP (figure 3).  
Therefore, ferrocyanide is not a suitable pumping species because at the potential needed to 
oxidize ferrocyanide to ferricyanide to create MHD pumping will also oxidize the PAP.  In 
addition, if both ferrocyanide and ferricyanide were present in solution so that oxidation and 
reduction of the redox species could both take place at tow electrodes (as in the reinforcing flow 
configuration in figure 2), homogeneous oxidation of PAP would also take place in a reaction 
with the ferricyanide in the bulk solution. 
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Figure 3 shows that PAP and ferrocyanide are electrochemically indistinguishable. 
 
 Another redox species that was investigated for microfluidic pumping with MHD was 6 
mM ruthenium (II) hexamine (ruhex).  The ruhex is able to oxidize at a negative enough 
potential that PAP is left undisturbed (figure 4).  This makes ruhex a suitable MHD pumping 
species.  A mixture of the oxidized and reduced forms of ruhex could be used in a reinforced 
MHD flow method to increase solution flow rate.  
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Figure 4  shows that the oxidation of ruhex is distinguishable from the oxidation of PAP, making ruhex a suitable 
pumping species. 
 
The studies involving ferrocyanide led us to try MHD directly with a solution of 4 mM 
PAP alone in Tris.  The argument supporting this simplified composition is that if the oxidation 
state of the PAP is going to be changed as a consequence of pumping, then it is not necessary to 
ad any additional species.  Also, we would know exactly the amount of PAP we added to start 
with and could then determine any additional species generated by the reaction of AP with PAPP 
by difference in the signal (figure 5).  Of course, the compatibility of PAP and immunoassay 
components is already well known.  The current from the enzyme-generated PAP would be 
proportional to the amount of analyte (or antigen) captured by the assay. 
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Figure 5  shows a CV of 4 mM PAP and the expected CV of 4 mM PAP and 4 mM PAPP in the presence of AP.   
 
MHD Effects Seen in 4 mM PAP.  The reinforcing MHD flow method was used to observe 
bead movement in 4 mM PAP.  In these experiments, the speed of the beads is assumed to be a 
good estimate of solution flow velocity.  Because only PAP oxidizes, flow in a circular path 
around the anode was observed.  However, because there was no other species that could reduce 
at the potential held at the cathode, the current there was negligible, and therefore, no flow was 
observed there. 
 
A chronoamerogram (CA) was taken at the anode and the absolute current over time was 
plotted (figure 6). 
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Figure 6 shows an initially high current followed by a steady state current. 
 
The CA of 4 mM PAP showed a high initial current.  Due to this high Faradaic transient 
when the CA is started, the higher ion flux results in a larger FMHD.  This manifests itself as a 
higher bead velocity at early times.  As time passes, the current decreases, reaching a steady 
state.  The bead velocity is correspondingly slow to a steady-state, as well as, expected from the 
cross product relationship of j and B. 
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Figure 7 shows the initially high bead speed, which becomes steady over time. 
 
The higher the current, the larger the ion flux, the greater the MHD force and the faster 
the beads move (figures 6 and 7).  The fastest speed that beads traveled was 17.1 μm/s.  This is a 
sufficient flow rate for building an immunoassay and is competitive with other MHD fluid 
velocities (that range from 1 μm/s to 1 mm/s) reported in the literature for solutions that do not 
contain redox species.  The added advantage of the redox species is that electrode corrosion and 
electrolysis of solutions (that produces bubbles) are avoided. 
 
Conclusion 
 
 This research found two suitable redox-MHD pumping species that can be used at very 
low concentrations (4-6 mM)  and would be expected to be compatible with immunoassay 
components (ruthenium (III) hexamine and PAP in Tris buffer).  Ruhex is a good pumping 
species because both its oxidized and reduced forms are compatible with PAP, making it a good 
species for reinforced MHD flow.  PAP alone can serve as a pumping species and it is known to 
be compatible with immunoassay components.  The added current from the enzyme generated 
PAP over the starting PAP signal would be proportional to the analyte in an assay.  Changes in 
signal of 1/10 should be easily quantifiable, and sufficient for analysis by immunoassay.  This 
paper also reports solution flow up to 17.1 μm/s in a 4 mM solution of PAP (in Tris).  This value 
is competitive with velocities reported in the literature for non-redox MHD, which range from 1 
μm/s to 1 mm/s.  If we make use of the reinforcing flow configuration with the use of both 
oxidized and reducd forms of ruhex, we expect that velocities of at least 2.5 times will be 
achievable8.  Future work will involve reinforcing flow investigations and other electrode 
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geometries to optimize velocities while keeping the pumping species concentration low.  A 
complete immunoassay will also be performed in the presence of the compatible redox pumping 
species under optimized conditions to demonstrate the utility of redox-MHD for LOAC 
applications. 
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The Enhancement of In Vitro Microdialysis Recovery of       
        Interferon-γ Using Affinity Agents 
Chris Ladner, Spring Hill College 
Mobile, Alabama 
 
 
Abstract 
 
Microdialysis is a common way to sample small, low molecular weight analytes.  In living 
tissue it has become increasingly important to study small signaling proteins called 
cytokines, which are vital for cellular communication.  One cytokine of interest is 
Interferon-γ (IFN-γ).  This cytokine plays a major role in immune response to foreign 
agents and it is of interest to know concentrations of IFN-γ in living tissue. One issue that 
arises with cytokine microdialysis is a general low relative recovery.  Some affinity agents, 
such as heparin, can bind cytokines and increase relative recovery.  This project aims to 
study the relative recovery of Interferon-γ using microdialysis.  To this end, two known 
affinity agents, heparin and the detection antibody for IFN-γ, were used to increase the flux 
of cytokine into the microdialysis probe.  Dialysate samples were collected and analyzed by 
ELISA.  
 
Introduction 
 
In living tissue it has become increasingly important to study small signaling proteins 
called cytokines.  These proteins are vital for cellular communication.  In the fields of 
pharmacokinetics and neuroscience, it is especially important to have a quantitative measurement 
of cytokine concentrations.  Until recent years it has been very difficult to get real time 
information on cytokine concentrations in living tissue.  Microdialysis sampling is widely used 
to sample cytokines.  In vivo, a small microdialysis probe is inserted into the tissue.  A buffer 
solution is perfused through the probe and cytokines diffuse through the membrane.  A sample 
can be collected in few hours and can give close to real time data of cytokine concentrations.  
Also, microdialysis is reasonably inexpensive and is less evasive then previous sampling 
techniques.   
  
One issue that arises with collecting cytokines via microdialysis is a general low relative 
recovery (RR). 
sample
collected
C
CRR =            (1) 
This is due to several factors including, size and conformation of the cytokine, interactions 
between the cytokine and the probe, and flow rate of perfusion fluid.  The use of affinity agents 
is now commonly used to increase cytokine recovery.  Affinity agents can bind to the cytokine 
and change the concentration gradient, effectively enhancing the flow of the cytokine into the 
probe.  Heparin, a naturally occurring glycosaminoglycan, is negatively charged and can bind 
several common cytokines.1, 2  Recent studies have shown an increase in relative recovery with 
perfusion fluid containing heparin.3, 4  Cytokine antibodies have also been used to increase 
relative recovery. 
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 One specific cytokine of interest is Interferon-γ.  It is the only member of the type II class 
of interferons.  Interferons are naturally occurring proteins produced by cells of the immune 
system in response to foreign agents, such as viruses.  Specifically, IFN-γ activates natural killer 
cells and macrophages, up-regulates antigen presence in lymphocytes, and induces resistance of 
host cells to viral infection.5  A bioengineered form of IFN-γ has been used in children and adults 
with chronic granulomatous disease and severe, malignant osteopetrosis.  Because IFN-γ can 
also cause inflammation, it may be of interest to know specific concentrations of the cytokine 
during infection.  This study aims to use affinity agents to increase the relative recovery in vitro 
microdialysis sampling of IFN-γ.   
 
Experimental Procedures 
 
Materials 
Heparin Sodium Salt (Grade 1-A from Porcine Intestinal Mucosa) was purchased from Sigma-
Aldrich (St. Louis, MO).  Rat IFN-γ ELISA kit was purchased from BD Biosciences Pharmigen 
(San Diego, CA).  Rat IFN-γ standards from the ELISA kit were used in all experiments. The 
buffer for all experiments was the ELISA kit buffer (PBS with 10% FBS, pH 7.0).   
  
Microdialysis 
For all microdialysis experiments the CMA/20 (10mm) Polyethersulfone (PES) probes with 
100kDa cut off (CMA/Microdialysis AB, Stockholm, Sweden) were used.  The probes were 
connected to CMA402 syringe pumps (CMA/Microdialysis AB, Stockholm, Sweden).  The 
assay diluent from the ELISA kit was used as the perfusion fluid.  For all experiments the sample 
fluid contained 2000 pg/ml IFN-γ/assay diluent.  A control was run simultaneously, containing 
only assay diluent.  Sample fluid was collected every hour for measurement to assure the 
cytokine concentration stayed constant.  For the Heparin experiments, flow rates of 2μL/min and 
1μL/min were used.  The perfusion fluid contained 10μM Heparin.  A volume of 120μL was 
collected for analysis.  For the antibody experiments the ELISA biotinylated anti-rat monoclonal 
detection antibody was used in the perfusion fluid (1.6 nM).  A flow rate of 1μL/min was used.  
A volume of 125μL was collected for analysis.   
 
ELISA 
For both experiments IFN-γ concentrations were determined using the ELISA kit.  The samples 
were analyzed with a Tecan Infinite M200 multifunctional microplate reader (Tecan Group 
Mänedorf, Switzerland).  Fluorescent absorbance was measured at 450nm and subtracted at 
570nm.  The Heparin experiment samples were analyzed according to the ELISA protocol by 
BD Pharmigen.  The detection antibody samples were analyzed using a modified ELISA 
procedure.  In the modified procedure the cytokine samples were prepared and incubated with 
detection antibody before being added to the microwells as opposed to the standard protocol, 
which requires addition of the antibody after the samples have incubated in the microwells.     
 
Results and Discussion 
 
Heparin Samples 
Different concentrations of Heparin were added to standard IFN-γ to test for interference with 
the ELISA assay. The graph is presented in Figure 1. Heparin concentrations up to 10μM appear 
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to not interfere with the assay. Microdialysis samples with heparin in the perfusion fluid were 
collected at two flow rates and analyzed. The relative recovery is presented in Figure 2. As 
expected the microdialysis yielded a small relative recovery. The heparin added to the perfusion 
fluid did not appear to increase RR. This may be due to the binding kinetics of heparin and IFN-
γ.    
 
Detection Antibody Samples 
Detection antibody was incubated with IFN-γ at different time periods to test for interference 
with the ELISA assay.  The graph is presented in Figure 3.  Only the twelve hour incubation time 
appeared to significantly affect the assay. Microdialysis samples with antibody in the perfusion 
fluid were collected over two different time intervals and were analyzed.  The relative recovery 
is presented in Figure 4.  For the two hour collection time, the antibody sample had too low of an 
absorbance.  The control sample yielded a similar result to the heparin control.  At the four hour 
collection time, the antibody sample did have absorbance, but did not significantly increase RR.  
Because this is a modified ELISA procedure, the incubation or concentration of antibody may 
need to be adjusted.   
 
Conclusion 
 
Interferon-γ microdialysis samples were successfully collected using affinity agents. Both 
heparin and the detection antibody did not show interference with the ELISA procedure, which is 
used to analyze the samples.  Though they do not interfere, the affinity agents do not appear to 
significantly increase the relative recovery of the IFN-γ.  Interestingly, the detection antibody 
method could be a viable way to collect cytokine.  Since the antibody is used in the ELISA 
procedure, it could lead to cost effective ways to collect and analyze cytokines.  In future work 
different cytokines may be tested with these procedures.    
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Figure 1:  Log-Log graph of Interferon-γ and varying concentrations of heparin.   
 
 
 
 
Microdialysis with Heparin 
Flow Rate IFN-γ/Buffer IFNγ/Heparin 
2 μL/min 1.31% 1.13% 
1 μL/min 1.71% 1.80% 
   Figure 2:  Microdialysis relative recovery of Interferon-γ with heparin. 
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Figure 3:  Log-Log graph of Interferon-γ incubated with detection antibody at different time 
periods. 
 
 
 
 
 
Microdialysis with Antibody 
(1 μL/min) 
Collection Time IFN-γ/Buffer IFNγ/Antibody 
120 mins 1.88% N.A. 
240 mins 0.80% 1.23% 
        Figure 4:  Microdialysis relative recovery of Interferon-γ with detection antibody. 
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Enhanced Recovery of Cytokines in vitro: A Microdialysis Study 
William Newhart, Missouri Western State University 
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Abstract 
 
Microdialysis is a well known sampling method that uses concepts of simple diffusion to 
extract analyte concentrations from various tissues of a living organism. Recent studies 
using this sampling technique have focused on quantifying signaling proteins called 
cytokines, but have had little success due to the cytokines low diffusion coefficient and 
concentration in vivo. The purpose of this study was to analyze heparin for its ability to 
increase the RR of selected cytokines in vitro and interfere with the quantification of such 
cytokines with ELISA protocols. Heparin is a naturally found polysaccharide that has a 
high binding affinity to many types of cytokines. In this study, the relative recovery of the 
cytokine MCP-1 was shown to increase with heparin concentration, but possible 
interference by heparin of the ELISA analysis was observed. Cytokine RANTES was 
shown to possibly display high dose hook effect with a modified ELISA protocol. A 
significant difference in dialysate collected between 0% and 1% BSA was also observed in 
an independent assay. 
 
Introduction 
 
 Microdialysis is a well known sampling method that uses concepts of simple diffusion to 
extract analyte concentrations from various tissues of a living organism. The principle procedure 
in any microdialysis study involves pumping a perfusion fluid through a semi-permeable probe 
that is placed in tissue or solution. In theory, higher analyte concentration on the outside of the 
probe causes diffusion of the analyte through the probe via pores with a molecular weight 
restriction. Sample fluid collected, called dialysate, is then pumped out into a collection vessel 
for further investigation.1 Normally, effective removal of the of the analyte from the sample 
media is described in terms of it’s extraction efficiency (EE), expressed as the following 
equation below, where Cd, Ce, and Ci are the concentration of the analyte in the dialysate, 
sample media, and perfusion fluid respectively.2  
 
EE = (Cd – Ci) / (Ce - Ci) (1)     
 
If Ci = 0, then the EE is referred to as the relative recovery (RR).2  
 
Since its modern conception in the early 1980’s, microdialysis has been used to 
investigate the concentration of neurotransmitters and small molecules such as dopamine, 
acetylcholine, noradrenalin, and glucose in vivo. The method has been used in conjunction with 
separation and detection instrumentation such as liquid chromatography, capillary 
electrophoresis, and currently with positron emission tomography (PET) for aiding in 
validation.3 In recent years, the technique has focused on sampling various types of proteins in 
living tissue.4 These molecules have posed significant problems to the sampling techniques 
because of their relatively low concentrations in-vivo and their low diffusion coefficients through 
tissue.4 Factors including molecular weight, ionic charge, and hydrophobic interactions also 
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amplify the difficulties of sampling with a semi-permeable membrane probe of set molecular 
weight cutoff (MWCO).4 Then there are the difficulties of probe design, calibration, and wound 
response in vivo that encapsulates the probe, thus hindering accurate collection over a long 
periods of time.2 A specific classification of proteins called cytokines are of particular interest to 
the microdialysis community. These proteins are especially important for study because they are 
responsible for communicating and signaling a wide variety of responses relating to immunity, 
wound healing, and cell differentiation.5  
 
 A current approach to increasing the RR of cytokines in vitro and vivo has been the 
application of chemical agents that bind or alter the analyte passing into the probe so that it 
cannot diffuse back into the media. Current attempts have included using microbeads bound with 
antibodies specific to a single cytokine with flow cytometer detection.5 However, saturation of 
the capture sites on the beads has lead to investigating the use of more non-specific, cost 
effective agents. One such agent has been the use of heparin. This repeating polysaccharide binds 
very well to variety of cytokines and is relatively inexpensive to obtain, making it an ideal 
candidate for studying cytokine detection in vivo.6 
  
The purpose of this study was to analyze heparin for its ability to increase the RR of 
selected cytokines in vitro and interfere with the quantification of such cytokines with ELISA 
protocols. For this study monocyte chemoattractant protein (MCP-1) and Regulated upon 
Activation, Normal T-cell Expressed Secretion (RANTES) protein was analyzed with heparin. 
MCP-1 is a homodimer that activates several types of nonspecific and specific immune 
cells.7 The relevance of quantifying MCP-1 grows when considering it has been supported to 
help in the hardening of arteries in mice with high cholesterol.7 RANTES, also a homodimer and 
activator of immune cells, has been studied to share a common protein receptor for HIV-1 
infection.8  Being able to accurately quantify these cytokines could give key diagnostic markers 
for particular cell infections and pathologies. 
  
Experimental Procedures 
 
BSA Flow Rate Assay 
 Bovine Serum Albumin (BSA, Sigma Aldrich) was prepared to concentrations of 1 to 4% 
in phosphate buffered saline (PBS, 100 mM, pH 7.4). After overnight equilibration of solution at 
4 0 C, BAS microdialysis pump with self-assembled triple syringe bracket was used to perfuse 
500 uL of each respective BSA solution through a CMA-20 14/10 PES microdialysis cannula 
probe (CMA, Stockholm, Sweden 100 kDa MWCO) that was submerged in 1 mL of sample 
media consisting of the same composition as the perfusion fluid. Dialysate collection vials were 
massed before and after sampling and were kept at the same height on the lab bench as the 
sample media vials and syringes. Probes were flushed before assay with distilled water for 30 
minutes at 3 µL/min using 1000 µL BAS glass syringes. BSA solutions were allowed to flush 
through probes after flushing with water for 20 minutes at 2 µL/min to flush probes with 
experiment’s perfusion fluids. Three trials apiece were conducted for each BSA concentration 
for 1 hour at 2.0 µL/min. Room temperature was recorded at 230. Control assays were performed 
three times with the same PBS solvent with the same parameters. Density of each BSA solution 
was performed via massing 1.00 mL aliquots into unused, pre-massed centrifuge tubes. Three 
density values were calculated per BSA solution and an average was calculated. The average 
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density was used to solve for the average volume of each individual trial per BSA solution. 
Average volume with error was then calculated for each solution and control and a percent 
recovered volume was calculated based on the theoretical volume of solution pipetted. ANOVA 
single factor t-test at 95% confidence was performed for all BSA together and only for 1%, 2%, 
and 4% BSA. 
 
Heparin Interference Assay with MCP-1 
 ELISA protocol from BD Pharmingen (BD Biosciences, San Diego, CA) was used to run 
control and spiked MCP-1 standards. Heparin sodium salt from porcine intestinal mucosa (Sigma 
Aldrich, H3149) was used to create 20µg/mL, 0.2µg/mL, and 0.002µg/mL heparin solutions 
dissolved in assay diluent as ordered from BD Pharmingen (10% FBS in PBS: 80g NaCl, 11.6g 
Na2HPO4, 2.0g KH2PO4, 2.0g KCl, q.s. to 10 L; pH to 7.0). ELISA protocol followed according 
to BD. Heparin samples added to wells in 50 µL amounts to 50 µL of appropriate MCP-1 
prepared standards so that final volume was protocol recommended 100 µL per well and that the 
MCP-1 standard and heparin were at the desired concentrations. All controls (no heparin added) 
and spiked standards were run in duplicate. Standards made as recommended from 1000-31.25 
pg/mL via serial dilution. BD Falcon 96 well flat bottom transparent plate used for assay was 
read via Infinite Optical Scanner for Absorbance at 450 nm with a 570 nm recommended 
reference. Standard curves were generated according to BD ELISA protocol for all samples and 
slopes were compared to the control standard. 
 
MCP-1 Microdialysis with Heparin 
 MCP-1 sample media (2000 pg/mL, BD Pharmingen) was prepared according to protocol 
recommendations in prescribed assay diluent. BAS microdialysis pump used with 3 syringe 
bracket to perfuse either 0, 1, or 10 µM heparin concentrations prepared in BD assay diluent. 
One syringe was used per heparin concentration and 3 trials were conducted per perfusion fluid 
at 1.0 µL/min until a total volume of 390 uL was collected altogether. 300 µL of sample media 
was taken before and 300 µL of media was taken after each heparin solution was perfused 
through the probe. Dialysate collected was kept on ice while sampling and both dialysate and 
sample media vials were covered with parafilm during the sampling. Heparin solutions were 
prepared from stock (1009 µg/mL) prepared by dissolving massed amount of Heparin sodium 
salt from porcine intestinal mucosa (Sigma Aldrich, H3149) in BD assay diluent. The molecular 
weight of the heparin was taken from reported literature values to be 12,000 g/mol. CMA probes 
used for the BSA assay were used and flushed with BD assay diluent at 2.0 µL/min for ~20 
minutes before sampling. Samples were collected and stored at 4oC overnight.  
  
Samples were quantified via MCP-1 ELISA protocol from BD Pharmingen on a BD 
Falcon 96 well flat bottom transparent plate. 2000 pg/mL standard prepared for the microdialysis 
sampling was used to prepare all ELISA standards serially diluted according to protocol (1000-
31.25 pg/mL). Standards were run in duplicate and spiked standards were prepared in the same 
manner as referred in the MCP-1 interference assay but using 20, and 2 µM prepared heparin 
solutions from 1009 µg/mL stock. Sample media before microdialysis and sample media 
perfused with control (0 µM heparin) was run only a single time due to plate size restrictions. All 
other dialysate and sample media after microdialysis were run in duplicate. Standard curves were 
generated for each heparin concentration according to BD Pharmingen protocol. Regression lines 
were used to calculate RR for the average dialysate concentration calculated from the absorbance 
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values. Sample media concentrations before and after microdialysis sampling were averaged to 
generate an average media concentration used to calculate percent RR. Averages and standard 
deviations were also calculated for each RR. 
 
RANTES Interference Assay with Heparin 
 ELISA protocol from Preprotech (PREPROTECH, Inc., New Jersey) was used to run 
control and spiked RANTES standards. Heparin sodium salt from porcine intestinal mucosa 
(Sigma Aldrich, H3149) was used to create 20µg/mL, 0.2µg/mL, and 0.002µg/mL heparin 
solutions dissolved in assay diluent as ordered from BD Pharmingen. ELISA protocol modified 
from Preprotech in that assay diluent from BD was used in steps to block wells, add standards, 
samples, detection antibody, Avidin-HRP Conjugate, and using BD substrate solution to measure 
absorbance. Addition and incubation of BD substrate and stop solutions were followed according 
to BD protocol for the first two assays due to lack of Preprotech reagents prescribed. Third assay 
modified by using recommended diluent for standard and sample addition via preparation the 
day of assay (0.05% Tween-20, 0.1% BSA, in PBS) and substrate incubation time was modified 
from 30 minutes (BD prescribed) to stopping reaction upon observation of homogeneous color 
over the well plate. Heparin solutions added to wells with RANTES standards so that final 
volume was 100 µL and both RANTES and heparin were at desired concentrations. All controls 
(no heparin added) and spiked standards were run in duplicate. Standards made as recommended 
from 1000-31.25 pg/mL via serial dilution. BD Falcon 96 well flat bottom transparent plate used 
for assay was read via Infinite Optical Scanner for Absorbance at 450 nm with a 570 nm 
reference as advised by the BD protocol when using BD substrate solution. Standard curves were 
generated according to BD ELISA protocol for all samples and compared to the control standard. 
  
Results and Discussion 
  
BSA Flow Rate Assay 
In microdialysis sampling, addition of BSA to perfusion fluid is a way to decrease of the 
effect of ultrafiltration, where fluid loss occurs due to hydrostatic pressure.1 This fluid loss will 
lower dialysate volume and give inaccurate measurements to the recovered dialysate. BSA also 
functions to hinder non-specific adsorption of the cytokines to the inner lining of the tubing. 
Table 1 shows the average volume recovered from each microdialysis probe perfused with a 
single BSA concentration through a sample media of that same concentration. Single factor 
ANOVA gave F-values for 0, 1, 2, and 4% BSA recovered volumes to be 6.41 with Fcritical = 
4.07. ANOVA for the comparison of 1, 2 and 4% BSA average recovered volumes gave F = 2.85 
and Fcritical = 5.14. These F values support that there is a significant difference in the average 
recovered volume of BSA solution between 0% BSA and 1%, 2%, and 4% BSA. Error in the 
pump’s calibration was deemed not significant after two assays with three trials each (data not 
shown). 
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Percent BSA Avg. vol. 
in uL (n=3) 
Standard 
Deviation 
0% 100.54 0.0099950 
1% 116.27 0.0029800 
 
2% 113.58 0.0025900 
4% 116.87 0.0017010 
Table 1 - Average volume and standard deviation of dialysate collected after microdialysis perfusion of PES probes 
with stated percent concentrations of BSA in prepared PBS. Assays were run at 2.0 µL/min for 60 minutes. Actual 
volumes per trial calculated from average density (n=3) with respective BSA concentrations. Underlined values 
denote BSA concentration giving significant difference when compared via single factor ANOVA using Microsoft 
Excel® 
 
 
Heparin Interference Assay with MCP-1 
 It was an important aspect of this study to observe if heparin did interfere with the 
cytokine quantification via ELISA. The three cytokine concentrations tested were based on what 
is normally a high to low range of heparin perfused through a microdialysis probe. Upon 
observation of Figure 1, all spiked heparin standards seem to deviate from the control curve at 
the lower MCP-1 concentrations (125-31.25 pg/mL).  Addition of the substrate solution to the 
wells could be a factor to the deviation of the standard curves. A single tip pipette was used to 
add the 100 µL of substrate solution to each of the 56 wells used. The substrate could have 
longer times to bind to the detection antibody in wells pipetted first with substrate as opposed to 
wells pipetted last. This could vary the intensity of the absorbance of the assay and misrepresent 
the results. A statistical test in the error of each sample and control curve would need to be 
performed to give more certainty to the observed results. 
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Figure 1 – Log-log plot of absorbance versus of concentration of rat MCP-1 in ELISA assay to analyze for Heparin 
interference. Regression line refers to correlation of standard curve only. All other points refer to ELISA samples 
prepared to the same concentration as the standards, and with the labeled amount of Heparin sodium salt. 
Concentrations were 1000, 500, 250, 125, 62.5, and 31.25 pg/mL rat MCP-1 serially diluted from a 2000 pg/mL 
prepared stock. 
 
 
 
 
 
Heparin Concentration (µg/mL) Slopes 
0.0 0.6874 
0.001 0.7164 
0.1 0.6813 
10 0.5404 
Table 2- Slopes of Log-Log Regression Lines generated by Microsoft Excel® for standard curves of MCP-1 ELISA 
with spiked standards of heparin. All standard curves were run in duplicate and their absorbance values were 
averaged before plotting according to the BD protocol. 
 
 
MCP-1 Microdialysis with Heparin 
 The absorbance values for the 0, 1, and 10 µM heparin perfused dialysate was 
0.1501 +/- 0.003041, 0.2926 +/- 0.0969, and 0.1968 +/- 0.003645 respectively, n = 2 for all. 
Average concentrations for the sample medias before and after was 1261.0 +/- 71, 1110.5 +/- 
284, and 1104.0 +/- 293  pg/mL (n = 2) respectively for 0, 1, and 10 µM heparin solutions. These 
values gave percent relative recoveries of 8.41%, 18.34% and 21.20% respectively for 0, 1, and 
10 µM heparin dialysate samples, as graphically illustrated in Figure 2. While these percent RR’s 
indicate that heparin increased recovery, several factors come into consideration for the data. 
First, sampling media taken before microdialysis was analyzed one time on the ELISA due to 
plate size restrictions of fitting all necessary samples and standards. Normal standards and 
samples are run at least twice to obtain a more accurate average value. The time of microdialysis 
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sampling also came into question for error analysis. As previously stated, cytokines different 
chemical properties like hydrophobicity, and molecular weight cause problems for their 
sampling.4 A large factor of microdialysis sampling relies on flowing perfusion fluid at a high 
enough rate for a long enough time to attain an accurate representative sample of the solution or 
tissue. Another factor is the assay diluent itself contained fetal bovine serum (FBS), which has 
not had all its components separated and analyzed. There is a possibility that there are several 
proteins in the diluent that could also bind to the heparin and hinder MCP-1 from binding to the 
unbound heparin. Then there is the error associated with the ELISA itself. Normal allowable 
error in any immunological assay ranges from 15-20%. The percent RR was already low relative 
to the sample media’s initial concentration, thus any error in the normal range of the ELISA 
would misrepresent the recovery.    
 
 
 
 
Figure 2 - Relative Recovery of MCP-1 in vitro microdialysis sampling with different concentrations of heparin in 
perfusion fluid. Samples analyzed via ELISA protocol by BD Pharmingen. Linear regression equations per spiked 
set of standards used to calculate relative recovery. Dialysate samples trials run in duplicate on the plate. Sample 
media of each concentration run as a single well due to plate size restrictions. Percent RR for 0 µM, 1µM, and 10 
µM respectively were 8.41%, 18.34% and 21.20%   
 
RANTES Interference Assay with Heparin 
As with the MCP-1 ELISA, heparin could also interfere with the chemical analysis of 
RANTES. The ELISA for RANTES was performed on three separate occasions due to control 
and sample standards giving absorbance values that were over detection limits of 
instrumentation. Assay I (Figure 3a) gave over detectable absorbance values for all 1000, and 
500 pg/mL standards, as well as all but three 250 pg/mL standards which were for 0.1 and 0.001 
µg/mL heparin standards. There was only a single absorbance value for the 250 pg/mL standard 
run for the 0.1 µg/mL heparin, so an average absorbance could not be calculated, thus 
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contributing error. Assay II (Figure 3b) gave over ranged values for all 1000 and 500 pg/mL 
standards, including controls. Assay III (Figure 3c) gave only one well at 250 pg/mL spiked with 
0.1 µg/mL heparin over the detection range. The log-log plots of the standards that were 
detectable for Assay I and II appear to follow the standard curve. Assay III however appears to 
give a “hooking” pattern to the standards as the RANTES concentration increases. This 
observation is similar to the observed “Hooking” effect in ELISAs. This phenomenon occurs 
when high analyte concentration decreases the slope of the standard curve prepared (i.e. high 
dose hook effect).9 However, this effect was studied to be more prevalent in one-step ELISAs, 
where capture and detection antibodies are mixed with the analyte.9 The ELISA protocol used 
was a modified version for Assays I-II due to lack of recommended reagents. The recommended 
assay diluent was prepared for Assay III for locating the primary error in the standards. While an 
increase in number of detectable standards was noticed, the adding of the substrate solution to 
bind to the detection antibody may be another significant error. The BD Pharmingen substrate 
was not prescribed by Preprotech for this ELISA. High concentrated standards began reacting 
with the substrate within seconds after substrate addition. This was also observed in Assays I and 
II. The 30 minute incubation time recommended by BD for the substrate may react too quickly 
for RANTES. The shortened incubation time for Assay III was prescribed by the Preprotech 
protocol, which specified monitoring the reaction until a homogeneous color was observed over 
the plate. Incubating substrates for long periods of time would produce absorbance values over 
the detection limit of the instrumentation, especially for high concentration standards. 
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Figure 3B 
 
 
 
 
 
Figure 3C 
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Figures 3A,B,C, D – Log-log plot of absorbance versus of concentration of rat RANTES in ELISA assays I-III to 
analyze for Heparin interference (A-C). Regression line refers to correlation of standard curve only with no heparin. 
All other points refer to ELISA samples prepared to the same concentration as the standards, and with the labeled 
amount of Heparin sodium salt. Standards plotted for Assay I were 125-31.25 pg/mL for all standards and 250-31.25 
pg/mL for 0.1 and 0.001 µg/mL spiked standards. Standards for Assay II plotted were 125-31.3 pg/mL 
Concentrations of Assay III were 1000, 500, 250, 125, 62.5, and 31.25 pg/mL rat RANTES serially diluted from a 
2000 pg/mL prepared stock. (D) Table of each assay’s regression line slope. 
 
Conclusion 
 
 In analyzing BSA concentration versus flow rate, there was an observed significant 
difference in perfusing 0% and at least 1% BSA. There was also possible interference of the 
MCP-1 ELISA by BD Pharmingen with Heparin at low standard concentrations. Microdialysis 
of MCP-1 showed an increase in Relative Recovery as heparin in perfusion fluid increased. 
Possible hook effect also observed with the modified ELISA protocol of RANTES with heparin. 
Statistical analysis of error in standard curves would be a necessary step in giving certainty to 
results with heparin interference. 
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Exploratory Hierarchical Nanomachining of New Tertiary Hetero-
Micro/Nanostructures of ZnO
Sean Nomoto, University of Wisconsin-River Falls
River Falls, WI
Abstract
In this systematic exploration to synthesize tertiary nanostructures, primary microrods 
were made and used as substrates to produce secondary nanobranches, and the secondary 
growth was used as a substrate with increasing concentrations of 1, 3-diaminopropane 
(DAP) for tertiary nanobranches in order to determine the behavioral growth and 
appearance of the tertiary nanobranches. A concentration of ~120-140mM DAP in the 
tertiary synthesis yields an interesting type of nanobranch that gives the overall structure a 
cactus-like appearance.
Introduction
Zinc oxide has been studied extensively for its different structural growths that occur 
during hierarchical synthesis.  Zinc oxide has semiconducting properties with a wide band gap of 
3.37eV,1 and it has physical properties, strongly related to structural properties, that are worth-
while investigating so that many of the applications and devices utilizing ZnO can be better 
studied.2, 3 Some of the applications of interest are gas sensing,4 photon detection,5 light emitting 
devices (LEDs),6 transistors,7 and photocatalysis.8
Structure
The primary growth of the zinc oxide micro-rods is a crystallization of zinc oxide 
molecules that tend to favor a directional growth in the <0001> direction which is the direction 
normal to the plane of the base of the crystal.9 There also exists growth in the other directions 
but they grow at different rates.  The rates of growth for the directions are, ranked from highest 
to lowest: <0001>, <0110>, <0001>.9 Figure 2, from Li, et al, below on the left shows the 
directional growth of the hexagonal crystal.9 In Figure 2, the scanning electron microscopy 
(SEM) image on the right from Tierui, et al shows the primary ZnO growth.1
Figure 2.  On the left, the directional growths of zinc oxide are shown in this figure from Li, et 
al.9 On the right, SEM image of a ZnO primary rod from Tierui, et al.1
The primary micro-rod structure was demonstrated to have a hexagonal wurtzite structure 
as shown in Figure 1 above, and it has also been determined by X-ray diffraction (XRD) (P63mc,
a=3.2495 angstroms, c=5.2069 angstroms).2 The zinc oxide crystals are polar, and the overall 
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structure is such that the top planes of the crystal are mostly polar planes of zinc with faster rates 
of growth while the bottom plane is non-polar and composed of oxygen with the slowest rates of 
growth.10
Synthesis of Hierarchical Structures
The reactions that form ZnO are between zinc nitrate and hexamethylenetetramine 
(HMT) in a water solution.  The HMT becomes protonated by the water and reacts with zinc
ions, and the zinc hydroxide is formed from the Zn+2 reacting with H2O and further hydrolysis 
yields zinc oxide.  The zinc hydroxide can be hydrolyzed by the protonated HMT to produce 
zinc oxide.  Figure 1 below, from Yanhong Tong, et al, shows the reaction mechanism by which 
the zinc oxide is yielded.10
Figure 1.  The reaction mechanism with zinc nitrate and HMT shown in the equations from 
Tong, et al.10
In addition to the primary synthesis of ZnO, adding some diaminoalkanes to the reaction 
solution of HMT and zinc nitrate can cause further growth of nanobranches using the primary 
micro-rods as the substrate.11 In particular, 1, 3-propanediamine (DAP) has been used to study 
the systematic secondary growth and nucleation of ZnO.11 In Figure 3 shows the SEM image of 
the secondary growth of ZnO nanobranches.
Figure 3.  An SEM image of secondary nano-branches on a 
microrod from Tierui, et al
is shown.1
The nucleation of the secondary branches is dependent 
on a lower limit and an upper limit of DAP concentration.11
The lower limit, the critical nucleation concentration (CNC),11
describes the minimum concentration for nucleation to occur, and the upper limit is the limit of 
the zinc oxide solubility.11 Mae, et al describes the multiple effects of diaminoalkane molecules 
added to the reaction.  In addition the effects of molecules, such as zinc-amino complexes and 
increasing pH, the group has also shown that the secondary crystals on the primary substrate also 
have a hexagonal wurtzite shape as seen in SEM images.  
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The mechanism of secondary nucleation is not well understood, but Mae, et al believes 
that small holes, edges, and defect sites on (1010) facets of zinc oxide crystals serve as 
nucleation sites for secondary growth.11 Once the crystallization starts, crystals grow outward in 
a radial pattern to show six branches for each facet on the primary substrate.  The growth pattern 
of the secondary branches has been observed to first grow short branches with a greater density 
distribution, and as the concentration of DAP rises, the branches become longer and the density 
distribution decreases.11 According to Zhang, et al, concentrations of approximately 140mM will 
only cause the primary structures to increase in size to take the shape of a large pencil tip.  
Tertiary growth has not been extensively studied with DAP, but it has been investigated 
using other dimaminoalkanes.  A controlled synthesis of tertiary structures with butanediamine 
(DAB) has been well studied,12 and below in Figure 4, a tertiary structure produced with DAB is 
shown from Liu, et al.12
Figure 4.  On the right, a tertiary structure synthesized with the 
diaminoalkane DAB is shown, from Liu, et al.12
Experimental Procedures
A total of 54 ZnO primary microrods were synthesized by heating 54 ~15mL Teflon 
bottles with 10mL aqueous solutions of 20mM Zn(NO3)2 and 20mM HMT in a drying oven for 
17 hrs at 60°C.  To each Teflon bottle, a ~0.5 x 3 cm, clean piece of a microslide glass was 
added.  To glass substrates were cleaned by allowing them to soak in 2M HCl, then rinsing them 
with water, and drying them in an oven.  After the reaction was completed, the glass substrates 
were carefully washed and dried.  The morphology of the ZnO was determined by SEM.  Of the 
54 primary substrates, a set of 6 secondary structures were prepared by the identical method for 
the primary rods except for the following:  DAP was added in increasing amounts of 90, 95, and 
100µL, and the reaction was heated at 60°C for 4 hrs.  The morphology was analyzed by SEM.  
Another set of 5 secondary structures were made by the same procedure except the increasing 
amounts of the 98% DAP were 105, 110, 115, 120, and 125µL.  A set of 21 secondary structures 
were prepared by the same procedure except all had 100µL of DAP.  Of the 21 secondary 
structures made with 100µL DAP, 6 were used to synthesize tertiary structures by the same 
method except the increasing amounts of 98% DAP were 70, 80, 90, 100, 110, and 120µL.  The 
samples were coated with Au by a sputter coater and analyzed by SEM.  A second set of tertiary 
structures were prepared by the exact same procedure with no exceptions.  The second set was 
also analyzed by SEM.
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Results and Discussion
The SEM images of the sets of the tertiary synthesis showed that the growth occurred at 
70 µL of DAP, and then for the amounts between ~80-100 µL of DAP, unusual morphology of 
the tertiary began to appear.  Most of the tertiary growth appeared randomized about the center 
of the primary rod structure and about the secondary branches as well.  SEM images of samples 
with ~70 µL DAP are shown below in Figure 5, and these particular nanocrystals appear to be a 
state at which they are not fully developed.
Figure 5
Figure 5 (a) and (b) were synthesized in10 mL solutions of 20mM Zn(NO3)2, 20 mM 
HMT, and ~70 µL DAP heated at 60°C for 4 hrs.  These structures show little development in 
tertiary growth.  Whereas, in Figure 5 (c) and (d), prepared by the same procedure, show a state 
of growth that is much more developed. 
Contrary to the DAB tertiary growth, the DAP growth appear in needle-like branches, 
characteristic of the secondary growth with DAP.  Most structures appeared somewhat as 
expected, but with the higher amounts of DAP, the needle-like branches became larger in some 
cases while some needle-like branches remained small.  The most unusual structure obtained was 
a cactus-like structure that had tertiary growth on the top of the primary structure and on the tips 
of the secondary branches.  Figure 6 below shows the tertiary growth at the higher concentration 
of ~120-140mM DAP.  This morphology occurred twice at high concentrations of DAP, 
volumes of 110 and 120 µL of 98% DAP.  
d
(a) (b)
(c) (d)
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Figure 6  
Figure 6 (a), (b), (c), and (d) were prepared by the same method as the structures in 
Figure 5 except the volumes of DAP added were ~110-120 µL.  In Figure 6 (a), the tertiary 
growth appears to change into sparse, randomized nanobranches.  Figure 6 (b) shows 
nanobranches spreading outward onto the secondary microbranches, and then (c) shows the 
nanobranches growing on just the tips of the secondary microbranches.  Finally, in (d), the 
tertiary growth is shown exclusively on the ends of all the microbranches.
Conclusion
The growth habit of the ZnO tertiary structure may follow a trend of some form of 
regularity, but the morphology is not well understood.  More work must be done on the effect 
pH, time, temperature, ratios of amounts, etc., and work must also be done to study the physical 
properties of the new morphologies.
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Preliminary Characterization of the Binding of an Important Ras GTPase 
Binding Effector for Abnormal Cell Signaling Mutants  
of the Ras Protein Cdc42 
Nikita Patton, Bennett College for Women 
Greensboro, North Carolina 
 
Introduction 
 
Cell division cycle (Cdc42) is a GTPase protein in the 
Ras Superfamily. Ras proteins are responsible for 
regulating cell growth and cytoskeleton organization 
and Ras mutants are likely to be found in many 
different cancer type cells.1 Cdc42-GTP is the active 
state (GTP), Cdc42-GDP is its inactive state. When the 
Cdc42 begins to act in an overactive state, this leads to 
cell transformation. p21 activated kinase (PAK) is one 
an effector protein that interacts with Cdc42. Forty six 
amino acids of PAK known as 
Protein Binding Domain 46 
(PBD46) interacts with Cdc42 
to control its intake of GTP.3 4 
PBD46 contains the CRIB 
binding domain which is about 12 essential amino acids that directly 
interact with Cdc42. When a mutation occurs in Cdc42 at position 28 
where the phenylalanine amino acid is changed to leucine, the GTP/GDP cycle is more rapid 
which leads to cell transformation. This leads to cancer. This mutation is known as F28L. The 
structure of F28L is known but its binding complex is not.  The study of F28L is important 
because once phenylalanine is changed to leucine, there is no longer any pi 
conjugation found at site 28 which is changes the comformation of the 
protein. This could lead to a series of difficulties when Cdc42 F28L interacts 
with other proteins. Another mutation is referred to as ∆L8. This mutation is 
when the Rho insert region, amino acids 120 to 133, have been deleted from 
the protein‘s amino acid sequence. ∆L8 still allows spontaneous GTP/GDP 
exchange of the protein, but does not result in cellular transformation.5  
Currently, the structure and function of ∆L8 is unknown. 
 
The purpose of this experiment is to compare binding affinities of Cdc42 mutants F28L 
and ∆L8 to PBD46 compared to Cdc42 WT by in vitro binding assay.     
 
Experimental Procedures 
     
 Protein Expression: 
 Cells from a frozen glycerol stock were taken and used to start a 5 ml overnight culture of 
Cdc42 WT, F28L, and ∆L8 in an incubator at 37˚C. Inoculate 1% in 75ml of LB media to 
increase the number of cells. Cell growth and cell density (Optical Density) was checked by 
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measuring absorbance with UV spectroscopy at 600nm. The optimal reading is between 0.6-0.8. 
Induction of 1mM IPTG starts the growth of our protein of interest. Harvest was done with 
centrifuge. Expressions of our proteins were confirmed by Western Blot (WB). 
        
     Lysis: 
 Sonication was done to break open the cell and release the protein into lysis buffer (1x 
PBS, 10mM MgCl2, 0.1 mg/ml of lysozyme). Samples were incubated on ice for 1 hour, 
sonicated and were centrifuged at 20,000rpm for 30 minutes. The supernatant was collected to 
quantify our protein. 15µl of 1+1+ solution was added to to color and detect our protein with 
50µl of each cell lysate. All samples were heated at 75°C for 15 minutes to linearize the protein. 
A protein gel electrophoresis was done to quantify proteins.  
    
    “Pull Down” In Vitro binding assay:  
 The purpose of this is to determine if Cdc42 mutants F28L and ∆L8 bind to PBD46 
relative to Cdc42 WT. The cell lysate of Cdc42 WT, F28L, and ∆L8 were each tested binding to 
purified PBD46. GST was used as nonspecific binding controls with Cdc42 WT, F28L, and ∆L8. 
This was done to show that Cdc42 both the WT and mutants bind to PBD46 and not the GST tag. 
Each sample was combined in PBS buffer and 0.5mM GMPPCP. GMPPCP is a nonhydrolyzable 
analog that allows the terminal phosphate group to stay intact and not change into GDP. This 
must take place in order for PBD46 to bind to Cdc42. Then al incubated at 4°C for 4 hrs. Adding 
glutathione sepharose beads and incubate at 4°C for 1hr allows the bead to bind to PBD46 and 
pull it down once it has binds to Cdc42.2  Beads were washed with PBS buffer. To elute, wash 
with 20mM Tris 10mM glutathione buffer pH8.SDS-PAGE was then performed to visualize the 
quantity of PBD46  and GST being recovered from the process.  
  
A Western Blot was performed. In order to make the protein accessible to the antibody 
detection and to immobilize the protein, transfer the gel over to the nitrocellulose membrane. The 
membrane was rinsed with 5% nonfat milk to fill all the unoccupied spaces not filled with our 
protein and then incubated for 20-30 minutes at room temperature. All excess milk was removed 
and the membrane was rinsed three times with TBS-T buffer. Detect Cdc42 WT and mutants by 
adding the first anti N-terminus-His tag that binds to the His-tag and the secondary antibody goat 
anti-mouse IgG-AP. 5µl of the anti N-terminus-His tag that binds to the His-tag on the protein 
was added in 5ml of 0.2% BSA and TBS-T buffer and incubated for 5 hours. Both were rinsed 
with TBS-T buffer and 2.5µl of the secondary antibody goat anti-mouse IgG- AP were added in 
5ml of 0.2% BSA and TBS-T buffer. Incubate overnight. Wash with TBS-T.  For the enzymatic 
reaction to take place and develop the membrane, 7.5ml of TBS-MgCl2 buffer was added with 
25µl of BCIP and 50µl of NBT. This is done to verify that the protein that was pulled down and 
shown in the gel is our protein of interest. 10% Acetic acid is used to stop the reaction once all 
the protein is visible on membrane. 
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Data Collection 
 
 
 
 
 
 
 
 
 
 
Results and Discussion 
  
Figure 1 part A shows good expression levels of the Cdc42 WT and mutants. Figure 1 
part B shows that expression of a protein is very sensitive to initiation of induction. If 
exponential growth is very high, then the protein expression is lower. Figure 2 verifies which 
bands on the gel were our proteins of interest using WB. Figure 3 shows that in the In vitro 
binding assay, Cdc42 WT and mutants do bind to PBD46 and not GST tag. 
 
Protein Gel Electrophoresis Pull Down In Vitro Binding Assay 
Figure 1 Figure 2 
Figure 3 
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Conclusion 
 
This is just a qualitative study that shows that Cdc42 WT and mutants do bind to PBD46 
and not to the GST tag in In Vitro Binding Assay. An Optical Density reading between 0.5 and 
0.8 shows good expression of protein, anything higher shows very little protein expressed. 
 
Future Work 
 
Optimize the expression of mutants. Figuring out the optimal induction time that 
expresses more protein would be an improvement. Also, to quantify the binding parameters of 
PBD46 to each Cdc42 mutant compared to the wildtype. This could be done to determine how 
precisely each protein interact with each other with more detail. 
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Analysis of Methionine Sulfoxide from Urinary Proteins in Relation to 
Tobacco Use 
Ashley Ramsey, University of Arkansas at Monticello 
Monticello, Arkansas 
 
 
Abstract 
 
Methionine sulfoxide is a naturally occurring sulfone that is also caused by oxidants such 
as tobacco smoke. A method was determined to measure the amount of methionine 
sulfoxide in complex protein mixtures like urine and liver. Overall, the results show that 
methionine is oxidized more in smokers than in nonsmokers. Once the method was 
determined for the urine, it was applied to rat livers. The rats were injected with 
acetaminophen and their levels of methionine sulfoxide were increased. Acetaminophen is 
linked to acute liver failure and tobacco use is linked to many illnesses. These two are 
linked together by the oxidation of methionine.   
 
Introduction 
 
 Proteins are sensitive to oxidative damage and the biological effects are usually 
important.  Protein oxidation is proposed to contribute to the aging process because they are 
found to be increased in older organisms. Methionine is one of the easiest residues to oxidize 
even though it is not very common. The oxidation of methionine occurs in a wide variety of 
proteins. The oxidants found in biological systems, ozone, and cigarette smoke all have been 
shown to oxidize methionine in proteins and peptides. This oxidation tends to lower or even stop 
the biological activity of methionine. 
 
Oxidative stress in general is linked to the increased tendency of blood to coagulate, 
although the molecular mechanism is not yet completely clear. The blood of smokers is much 
more prone to clot than that of non-smokers. Cardiovascular diseases are the most common 
cause of premature death in smokers.1 The most common cardiovascular diseases in smokers are 
the thrombotic arterial occlusive diseases, in particular myocardial infarction (heart attack) and 
stroke.  
 
The oxidation of methionine is of major concern when proteins are used in 
pharmaceuticals. Oxidation of these proteins could occur readily during storage and might alter 
activity. The change in activity would be due to the alteration of the methionine. The side chain 
size and geometry would be changed but the sulfoxide is also very polar and hydrophilic. There 
is a large partial positive charge on the sulfur and a negative charge on the oxygen. This could 
lead to changes in the stability or in the ability of the binding site to work correctly.5   
 
"Acetaminophen toxicity is the number one cause of hospital admissions for liver failure 
in the United States."2  Before the 1980s, acetaminophen was not mentioned as a cause in case 
series of acute liver failure. A U.S. retrospective study from 1994 to 1996 found a 20% incidence 
of acetaminophen toxicity leading to acute liver failure.4  It is thought that acetaminophen may 
cause the oxidation of methioine in the liver.  
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Materials and Methods 
  
The procedure for the urine starts with a fresh sample that is taken first thing in the 
morning. The sample is collected in a 500mL sealed container and put on ice until it is used. The 
sample is divided into two equal amounts in the same size container. The samples are then put 
into a Sorvall RC-5B Refrigerated Superspeed Centrifuge for 15 minutes. A GS-3 rotor was used 
and the speed was 9,000 revolutions per minute and the temperature was 4ºC. The supernatant 
from the two containers was poured together. Fifteen micro liters of the supernatant was poured 
into a 50mL conical and 35mL of pure 100% ethanol was added. Another 50mL conical was 
prepared with water as to balance out the centrifuge. The conical with the sample was then 
cooled for 30 minutes at 4ºC. Then the conical were put back into the centrifuge in a SH-3000 
rotor. The time was 15 minutes, the speed was 4,700 revolutions per minute and the temperature 
was 4ºC. Afterwards, the conical were turned upside down over a paper towel to allow the 
ethanol to evaporate. 
  
Next the pellet is re-suspended in 3M methanesulfonic acid. The 3M methanesulfonic 
acid (MSA) was made by adding 68.6µL of concentrated MSA to 281.4µL of autoclaved de-
ionized distilled water (ddH2O). The solution was made in a 1.5mL Eppendorf tube. The MSA 
solution was put into the conical and the once the pellet was dissolved, the solution was 
transferred to a Peirce 10mm x 100mm 5mL vacuum hydrolysis tube. The solution was 
transferred by a 10cc plastic syringe with a 200mm metal needle attached. This was also used to 
remove the solution from the hydrolysis tube later. The cap of the hydrolysis tube was closed 
tightly.  
  
The hydrolysis tube was then thumped as to allow the gasses to rise to surface in the 
liquid. The hydrolysis tube was then dipped into a .5L nitrogen gas container and allowed to 
freeze. A slight cracking noise is heard when it is frozen. The tube is then removed and a vacuum 
hose is put on to the arm of the tube. A vacuum is applied and the top of the hydrolysis tube is 
loosened just enough to allow the vacuum to get into the bottom of the tube, but not enough to 
allow air to be pulled in through the top. The cap is then tightened back up quickly. The tube is 
then removed from the vacuum line and allowed to thaw before being put into a water bath. This 
part of the procedure is called freeze-pump-thaw and is repeated five times to ensure that all the 
gases have been removed.  
  
After the freeze-pump-thaw procedure, the hydrolysis tube is put into a pre-heated heat 
block for 2 hours. The temperature is 150ºC on the heat block. For a liver sample, the hydrolysis 
tube is left for 3 hours. After the heat block, the same cools to room temperature and is removed 
from the hydrolysis tube and put into a 50mL conical. The ddH2O is added to fill the conical to 
35mL. The solution is then vortexed to mix it.  
  
An ion exchange column is used in the next step. One gram of BIO-RAD AG 50W-X8 
Resin (200-400 Mesh Hydrogen Form) is put into a plastic BIO-RAD Poly-Prep 0.8 x 4cm 
chromatography column. The column is tapped on the lab bench to pack the resin down. Three 
milliliters of ddH2O was injected onto the top of the column. A cap was then put onto the top of 
the column and a syringe was put through the lid as to use it to push the water through the 
column. Everything that was put on the column was pushed through with this technique. After 
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the 3mL of water was pushed through, 3mL of .03M MSA was pushed through. Then the sample 
was injected 3mL at a time until it all had been pushed through. After the sample, another 3mL 
of .03M MSA was injected. All of the previous solutions were not kept. After the last 3mL of 
MSA, 3mL of 2M pyridine was pushed through. All of the eluent was kept from this step. The 
column was then washed out so it could be re-used. 
  
Five micro liters of the pyridine eluent were put into an Eppendorf tube. A redry solution 
was made with a 2:2:1 ratio of pure ethanol, ddH20, and triethylamine (TEA). The solution was 
mixed well and 10µL of it was added to the Eppendorf tube with the sample. A water blank was 
also made with the redry solution and 5µL of ddH20. The Eppendorf tubes were opened and 
were dipped into the liquid nitrogen container until the samples were frozen. This takes between 
5 and 10 seconds. This technique is called lyophilization and gets rid of the water by turning it 
into a gas. The tubes were then quickly put into a Savant Speed-Vac SC110 heated centrifuge. 
The centrifuge is connected to a vacuum line and pulls approximately 3mbar. The centrifuge was 
turned on high heat and high speed. The samples were left in the centrifuge for 30 minutes. Once 
the centrifuge has reached its top speed, the vacuum is turned on. After the 30 minutes, the 
vacuum is turned off along with the centrifuge and the samples are checked to see if they are dry.  
  
Once dry, the samples are derivatized. The derivatization solution consists of a 7:1:1:1 
mixture of pure ethanol, ddH2O, TEA, and phenyl isothiocyanate (PITC). The solution is made 
in an Eppendorf tube and vortexed to ensure it is mixed. Then 20µL of the derivatization solution 
is mixed with the sample. The tube is allowed to sit for 20 minutes with the derivation solution at 
room temperature. After this, the tubes are lyophilized and spun in the Speed-Vac the same as 
they were in the above step. This time the centrifuge is allowed to run for 40 minutes.  
  
After drying the second time, the samples are re-constituted in 100µL of Waters Pico-Tag 
Sample Diluent. The samples were sonicated to ensure they dissolved. Once dissolved, the 
samples were put into 300µL glass National Scientific inserts. The inserts were thumped to make 
sure all the air was out of the bottom. The inserts were then placed into a VWR International 
1mL clear shell glass vial. These were then loaded into the loading wheel of a Waters 717plus 
Autosampler to undergo reverse-phase high-pressure liquid chromatography. The HPLC consists 
of a Waters 600E Millipore System Controller, Waters 2996 Photodiode Array Detector, and a 
Waters 717plus Autosampler. HPLC-grade acetonitrile (MeCN) and ddH2O were each mixed 
with 0.1% trifluoroacetic acid (TFA) and used as eluents with a Phenomenex Jupiter Proteo 
250mm x 4.60mm column. The column was heated to 38ºC. Ten micro liters was injected of 
each sample. The method that was used was Atlantis TM 28FEB08. The method is shown below. 
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Time Flow Rate 
(mL/min) 
%ddH2O %MeCN 
----- 1.0 100 0 
2.0 1.0 65 35 
20.00 1.0 54 46 
20.50 1.0 0 100 
21.50 1.0 0 100 
22.50 1.5 0 100 
25.00 1.5 0 100 
26.00 1.5 100 0 
27.00 1.0 100 0 
 
 The standards that were used all underwent the drying and derivatization procedure that 
is listed above. The standards that were made were the water blank, amino acid standard, 
methionine standard, methionine sulfoxide standard, and a 5:1 amino acid/methionine sulfoxide 
standard. The water blank was only 5µL of ddH2O and then the redry solution. The amino acid 
standard was 5µL of Peirce Amino Acid Standard H and the redry solution. The methionine 
standard was made to be 100nmol. To get this molarity, 14.9 mg of 99% pure methionine was 
added to 1mL of ddH2O and vortexed. Twenty micro liters of this solution was then transferred 
to an Eppendorf tube and 80µL of ddH2O was added. This was mixed and 5µL of the solution 
was taken and added to 10µL of redry solution. The same thing was done for the methionine 
sulfoxide standard except 16.5 mg was taken and diluted. For the 5:1 standard, the same amount 
of the amino acid standard H was used and only 1µL of a 25nmol solution of methionine 
sulfoxide was used. The same amount of redry solution was added to all of the standards.3 
 
 The rat liver procedure was exactly the same as the urine except for the first few steps. 
The rat liver was allowed to thaw and then weighed out to be approximately 200 mg. Then the 
liver was cut into smaller pieces with a sterile razor blade and put into the hydrolysis tube. Here 
the MSA was added and the procedure starts at the freeze-pump-thaw step.  
 
Results and Discussion 
 
The following are the chromatograms from the analysis of the standards. With these 
chromatograms, we were able to see in which range the peaks of our interest were. The 
methionine comes out at approximately 17.5 on most of the chromatograms (graph1). The 
methionine sulfoxide normally came out at 11.2, (graph 2) but you can see that there are quite a 
few other peaks in that area (graph 3). To make sure we were using the correct peak, we spiked 
an amino acid standard with a methionine sulfoxide (graph 4) and analyzed it. This let us know 
for sure which peak we were looking at.  
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100 nmol methionine std. (graph1) 
100 nmol methionine sulfoxide std. (graph 2)
Amino acid std. (graph 3)
Amino acid std. (light gray), Amino acid std. spiked with methionine sulfoxide (dark gray) 
(graph 4)  
The next set of chromatograms is from the urine samples of smokers and nonsmokers. 
The peaks that are marked are the methionine sulfoxide at 11.2 minutes and the methionine at 
17.5 minutes. These graphs do not show very much until the ratios of the areas are measured. 
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Graph 9 shows 2 chromatograms lined up against one another. As you can see, the methionine 
sulfoxide peak is bigger for the smoker than the nonsmoker.  
 
TMU-3 (nonsmoker) (graph 5) 
 
TMU-7 (nonsmoker) (graph 6) 
 
TMU-110 (smoker) (graph 7) 
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TMU-114 (smoker) (graph 8)
TMU-7 and TMU-100 (the smoker is the darker gray) (graph 9)
The next chromatogram is of the rat liver samples. It has been normalized so the 
comparison of the peaks is easier to visualize. The control sample is just a normal rat. The other 
2 samples were injected with an overdose of acetaminophen. The rats were killed either 2 hours 
or 4 hours after the injection. Graph 10 clearly shows that the methionine sulfoxide peak is 
largest for the 4 hour sample and it decreases with the 2 hour and again with the control. The 
next graph (11) shows that the methionine peak does not correlate with the increase of 
methionine sulfoxide. 
(graph 10)
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(graph 11) 
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Conclusion 
  
The results from the urine studies show that there is an increase in the levels of 
methionine sulfoxide in smokers. The methionine level does decrease as the methionine 
sulfoxide level increases. On average, the ratio of methionine sulfoxide to methionine is higher 
for smokers than nonsmokers. For the rat livers, when the acetaminophen is injected, the 
oxidation of methionine follows the same trend as in the urine. The acetaminophen makes it 
increase over time. However, the levels of methionine do not decrease as methionine sulfoxide is 
increased. There will be future tests with mass spectroscopy to see if there is indeed something 
more to the methionine sulfoxide peak than what we think.  
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Development of Polyeugenol Coated Electrodes for Chemical Sensors 
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Abstract 
 
Oxygen sensing in AA/ACSF represents the most demanding case for oxygen sensing and is 
most similar to in-vivo use.  The electrochemical technique of cyclic voltammetry (CV) was 
used to electropolymerize a eugenol Filmover A gold electrode and to detect oxygen in KCl 
or AA/ACSF.  In this work, eugenol-coated gold electrodes were uniformly coated, tested 
for degradation, compared against Nafion® for linearity over a large concentration range 
of oxygen, and used to sense oxygen from potassium chloride (KCl), artificial cerebrospinal 
fluid (ACSF), and ascorbic acid in artificial cerebrospinal fluid (AA/ACSF).  It can be 
concluded that eugenol successfully protects the gold from fouling in AA with ACSF, while 
remaining permeable and sensitive to oxygen. 
 
Introduction 
 
There are many incentives to develop in-vivo oxygen sensors, including the ability to 
directly measure oxygen levels in brain tissue.  The brain depends on the constant, uninterrupted 
delivery of oxygen to prevent secondary injury.  Oxygen levels are known to vary in the brain 
and other tissues as a result of injury or stroke.  According to Littlejohns, et al., monitoring the 
partial pressure of brain tissue oxygen may help prevent hypoxia events and improve patients’ 
outcomes.1 
  
Currently, there are several methods of measuring oxygen levels in the brain in-vivo, 
Nuclear Magnetic Resonance (NMR), fluorescence quenching, or Electron Spin 
Resonance/Magnetic Resonance Imaging (ESR/MR); however, each of these methods has its 
own limitations, most notably with regard to the ability to make repeated measurements with 
minimum invasiveness and high sensitivity.2  Electrochemical detection presents one of the most 
promising ways of measuring brain tissue oxygen levels at different locations in the brain. 
  
One major problem with in-vivo oxygen sensing electrochemically is that bare electrodes 
foul on coming into contact with bio-components.  To prevent fouling, a protective coating is 
applied directly to the electrode surface.3  Traditionally, Nafion® has been the standard electrode 
coating, acting as an anionic molecular filter and limiting the access of large molecules to the 
electrode surface.  Nafion® is applied by a “dipping method,” which coats not only the electrode, 
but all of the inert structural materials surrounding the electrode.    
  
This paper reports on the performance of an alternative coating, electropolymerized 
eugenol, as a sufficient protective film for oxygen sensing.  The objective of this research was to 
determine whether eugenol-coated electrodes could be consistently and uniformly coated to 
become impermeable to large molecules, while still remaining permeable to oxygen. 
 In this work, eugenol-coated gold electrodes were uniformly coated, tested for 
degradation, compared against Nafion® for linearity over a large concentration range of oxygen, 
and used to sense oxygen from potassium chloride (KCl), artificial cerebrospinal fluid (ACSF), 
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and ascorbic acid in artificial cerebrospinal fluid (AA/ACSF).  Oxygen sensing in AA/ACSF 
represents the most demanding case for oxygen sensing and is most similar to in-vivo use.  The 
electrochemical technique of cyclic voltammetry (CV) was used to electropolymerize the 
eugenol and to detect oxygen in KCl or AA/ACSF.  Chronoamperometry (CA) was used to 
detect dissolved oxygen with both Nafion® and eugenol coatings and compare their performance 
over a large concentration range. 
 
Experimental Procedures 
 
Electrodes: 
The solution used for the dissolved oxygen experiments was a 0.1 M KCl (Fisher 
Scientific, Pittsburgh, PA) made with reagent grade deionized water (Ricca Chemical Company, 
Arlington, TX).  The dissolved oxygen concentration was lowered by bubbling nitrogen gas 
(AirGas, Springdale, AR) through the solution.  The dissolved oxygen concentration was 
measured by using a YSI (Yellow Springs Instruments, Ohio) model 55 Dissolved Oxygen 
Meter.  Two mm gold disk (CHI Instruments, Austin, TX) electrodes were used as working 
electrodes.  The gold disk electrodes were polished using 1.0 µm diamond polish, rinsing with 
deionized water followed by methanol (EMD Chemicals, Gibbstown, NJ), polishing again with 
0.05 alumina, rinsing again with both water and methanol.5 The electrode was then further 
cleaned in heated RCA-1 solution for 15 min. to remove any residual organic material before use 
in any cyclic voltammetry (CV) or chronoamperometry (CA) experiments.  RCA-1 solution is 
made of 4 mL 27% NH4OH (VWR International, West Chester, PA), 4 mL 30% H2O2 (VWR 
International, West Chester, PA), and 20 mL deionized water heated to 75°C.6  The reference 
electrode was a saturated calomel electrode (SCE) and the auxiliary was a platinum flag.  All 
chronoamperograms and cyclicvoltammagrams were obtained on a CHI 830 potentiostat. 
 
Calibration Curves: 
Both the YSI DO meter and the electrodes were placed in the test solution.  Operation of 
the YSI DO meter requires the solution to be stirred for accurate measurement.  However, any 
CV experiment requires a static solution.  To construct a calibration curve for the working 
electrode, the test solution was first stirred (Fisher Thermix Stirrer Model 120M) at a speed of 4, 
while nitrogen bubbled through the solution.  The gas flow was stopped around a DO reading of 
0.10 mg/L and any bubbles clinging to the working electrode and DO meter are knocked-off.  
Stirring continued until the first DO meter reading was taken at around 0.15 mg/L.  The magnetic 
stir was turned off, and CV or CA collected after waiting approximately five seconds for the 
solution to settle.  CVs were performed from +0.5 V to -1.0 V at 0.1 V/s.  CAs were taken from 
0.0 V to -1.0 V with a 15 sec. pulse width.  At the conclusion of the CV or CA experiment, the 
magnetic stirrer is turned back on and the DO concentration allowed too rise to the next level.  
This process continued until the DO level reached close to 6.50 mg/, oxygen saturation in 
ambient air.  A calibration curve was then constructed from the CV data points at -0.60 V or the 
CA data points at 14 sec.     
 
 
Film Formation: 
Nafion® membranes were cast on the working electrodes by pipetting 5 wt% Nafion® in 
alcohol solution (Aldrich, St. Louis, MO) onto the electrode surface and air drying for at least 
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one hour.  Films were formed such that different thicknesses could be achieved.  Film 
thicknesses was calculated (based on density) using a program on Excel spreadsheet provided by 
Dr. Johna Leddy’s group.7  For the purpose of these experiments only one thickness of 6 µm was 
used. 
 
Electropolymerization:8 
Eugenol was electropolymerized onto gold electrodes by sweeping the potential from 
+0.7 V to 0.0 V at 0.1 V/s for 40 sweep segments.  The electropolymerizing solution was a 10 
mM eugenol (Alfa Aesar, Ward Hill, MA) made with 0.1 M sodium hydroxide (Fisher Scientific, 
Pittsburgh, PA).  The films exclusion of large molecules was tested using 
hexaammineruthenium(III) chloride (RuHex, 10 mM, Alfa Aesar, Ward Hill, MA) made with 
0.1 M KCl .  Complete loss of the RuHex (III) signal was taken to mean that eugenol film was 
complete.  CVs in the RuHex were performed from +0.2 V to -0.5 V at a scan rate of 0.02 V/s.  
RuHex(III) exclusion was also used to test for degradation of the eugenol coating over time. 
 
Dissolved Oxygen Permeability: 
The solution used to test in-vitro dissolved oxygen permeability of the polyeugenol 
coating was 0.5 mM L-ascorbic acid (Alfa Aesar, Germany) in ACSF.  ACSF is a binary mixture 
and was made according to the recipe outlined by Ferriera, et al.4 The first solution contained 
117 mM NaCl, 4.69 mM KCl, 1.20 mM MgSO4·7H2O, 1.18 mM NaH2PO4, and 2.49 mM 
CaCl2.  The second solution contained 11.5 mM D-glucose and 24.9 mM NaHCO3.  The 
separate solutions were combined to yield the components in the present concentrations just 
before testing. All methods and parameters used for DO experiments in 0.1 M KCl solution were 
kept the same. 
 
Results and Discussion 
 
Dissolved Oxygen: 
The dissolved oxygen experiments were performed to practice experimental techniques, 
provide a reference, and to establish calibration curves.  Learning to collect CAs, CVs and using 
those to create accurate calibration curves was essential for data analysis.  It should be noted that 
the appearance of the oxygen CAs and CVs was never consistent from day to day.  Even when 
using the same electrode and test solution there were always some differences noted.  This is 
most likely due to changes of the electrode over time.  However, constructing calibration curves 
from peak currents at -0.6 V from CVs and any pulse step from CAs always provided linear 
calibration.5 
 
Advantages of Electropolymerized Films: 
The technique of chronoamperometry (CA) was chosen to compare the calibrations 
curves for oxygen obtained by of the polyeugenol coating to that of Nafion.®  Figure 1 shows the 
dissolved oxygen curves from varying concentrations using (CA).  In this technique, the 
potential of an electrode is instantaneously adjusted from a value with no net current, to a new 
value with a net current.  The magnitude of the resulting current decays continuously with time, 
but at any given moment is directly proportional to the concentration of the reactant in solution.9  
This is mathematically modeled by the Cottrell equation:10 
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where (I) is the current in amperes, (n) is the of moles of electrons per mole reactant, (F) is the 
Faraday (coulombs per mole of electron), (A) is the electrode area in sq cm, (t) is the time in 
seconds since the application of the potential pulse, (D) is the diffusion coefficient of the reactant 
in sq cm per sec, and (C) is the initial concentration of reactant in moles per cubic cm. 
  
Figure 2 shows that dissolved oxygen calibration curves resulting from the measured 
current of the CA at 14 seconds after application of -1.0 V step and indicates that the calibration 
curve using Nafion® is non-linear, while eugenol is linear.  Nafion® has long been the polymer of 
choice for coating electrodes.  It is easy to apply by a “dipping method,” but this method also 
coats the entire electrode/insulator assembly instead of only the gold electrode surface as seen in 
figure 3.  This can be a problem because the coating on the insulator surrounding the electrode 
creates a “trapped” oxygen effect.  The signal from “trapped” oxygen was found to be more 
pronounced using chronoamperometry (CA) than cyclic voltammetry.  The higher DO 
concentrations and shorter times cause the “bleed-in” of the “trapped” oxygen in the Nafion® 
coating to be worse due to the high concentration gradient within the coating. 
  
Overall it is apparent that eugenol is a better polymer for coating electrodes because it 
electropolymerizes only on the gold surface, eliminating the “trapped” oxygen effect seen in the 
Nafion® coating. 
 
 
  
Figure 1.  Overlay of CAs for Eugenol coated 2.0 mm Au electrode in KCl 
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Figure 2.  Dissolved Oxygen Calibration Curves for a 2.0 mm Au electrode coated with 
Nafion and Eugenol
Figure 3.  Nafion® and polyeugenol coatings on 2 mm Au electrodes
Good and Bad Eugenol Electropolymerization Coatings:
Figures 4 and 5 are the electropolymerization of eugenol onto the gold electrode surface.  
The electrode used in figure 4 was only mechanically polished before electropolymerization.  
The same electrode was cleaned in RCA-1 solution, and then electropolymerized to yield figure 
5.  The RCA-1 cleaning makes a very large difference in the data collected during 
electropolymerization and the performance of the resulting eugenol coating.  Permeability of the 
coating to large molecules was tested using RuHex(III).  Ideally, the coating should completely 
block RuHex(III).  Figure 6 shows the overlay of a CV of RuHex(III) with a bare electrode, the 
poor eugenol-coated electrode (from Figure 4), and the good eugenol-coated electrode (from 
O2 Endogenous O2 Endogenous
Nafion® Coating Polyeugenol Coating
Trapped 
O2 O2
Electrode insulator
Gold Surface
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Figure 5). The sharp increase in current on the bare electrode scan indicates the reduction of 
RuHex(III) to RuHex(II) and shows that the RuHex(III) has full access to the bare electrode.  
The CV of the poor eugenol-coated working electrode still has some of the RuHex(III) 
oxidation/reduction signals present, indicating that the RuHex(III) has not been completely 
blocked from the electrode surface due to an insufficient eugenol coating.  It can be seen that the 
insufficiently eugenol-coated electrode shows a RuHex reduction peak at -0.20 V.   However, the 
CV with the good eugenol-coated working electrode lacks the RuHex(III) oxidation/reduction 
signals, indicating that the RuHex(III) has been blocked from the electrode surface.  This 
confirms that the good eugenol coating was obtained by thoroughly polishing the electrode and 
then cleaning in the RCA-1 cleaning solution. 
  
Overall, it is possible to determine whether or not complete coatings are being produced 
just by examining the results of the electropolymerization CVs.  In addition, Figure 6 clearly 
shows that a good electropolymerization of a eugenol coating prevents large molecules, such as 
RuHex(III), from reaching the electrode.  A good eugenol coating was always obtained by 
polishing the electrode and then cleaning with the RCA-1 cleaning solution.  Failure to clean 
with RCA-1 consistently resulted in a poor coating.   
 
 
Figure 4. Poor eugenol electropolymerization on a 2.0 mm Au electrode 
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Figure 5. Good eugenol electropolymerization on a 2.0 mm Au electrode 
 
 
Figure 6.  Effect of good and bad eugenol coatings on a 2.0 mm Au electrode in RuHex(III). 
 
Degradation Studies: 
Once formed over the electrode, a limited attempt was made to determine the stability 
and shelf –life of the eugenol films.  Films were tested by determining permeability to RuHex 
(III).  The first day, the eugenol-coated electrode was simply stored in DI water and tested for 
impermeability to RuHex.  On day two, the same electrode was used to make DO calibration 
curves in ACSF and then stored in DI water for another 24 hours.  On day three, the same 
electrode was again used to repeat the DO calibration curves in ACSF.  Figure 7 shows that the 
eugenol-coated electrode actually becomes more sensitive to oxygen after exposure to ACSF.  
The CV taken after day one shows no RuHex peak present, which implies no eugenol 
degradation will occur after one day of storage in DI water.  The CV taken after day two shows 
that even after the eugenol-coated electrode was used in ACSF to construct a calibration curve, it 
is still impermeable to RuHex, while becoming more sensitive to oxygen. The CV taken before 
day three still shows no RuHex peak present, but it has become less sensitive to oxygen after 
storage in DI water.  The CV taken after day three still shows no RuHex peak present, but it has 
become even more sensitive to oxygen after a second use in ACSF.  No degradation of the 
polyeugenol film was evident even after three days of experiments.   
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(A) After Day 1 - only DI water storage
(B) After Day 2 – First use in ACSF, stored in DI water afterwards
(C) Before Day 3 – After storage in DI water from Day 2
(D) After Day 3 – Second use in ACSF
Figure 7.  Overlay of CVs for Eugenol coated 2.0 mm Au electrode in RuHex before and 
after use in ACSF
Performance of Eugenol coated Au electrode in AA with ACSF:
Figure 8 is the overlay of CVs recorded to determine the oxygen sensitivity of the bare 
2.0 mm Au electrode in ACSF.3 The data show no relationship between peak current and 
dissolved oxygen concentration.  Repeated experiments yielded similar results.  It can be 
concluded that a bare gold electrode cannot be used to sense oxygen in-vitro due to fouling.  By 
some mechanism, the gold electrode becomes insensitive to oxygen, most likely, due to the 
reduction of glucose obstructing the electrode surface.
Conversely, figure 9 is the same experiment as in figure 8, but with a eugenol coated 
electrode. This illustrates that the eugenol coating is able to protect the gold electrode from 
fouling while still remaining permeable and sensitive to oxygen.  While detecting dissolved 
oxygen in the AA/ACSF mixture, it was observed that the dissolved oxygen meter was unable to 
detect more than 4.48 mg/L.  This is a much lower reading than normally obtained, even when 
only ASCF is used as seen in figure 10.  In many recent studies, it has been found that the rate of
consumption of dissolved oxygen is directly dependent on the concentration of AA.11,12 The 
homogeneous reaction between oxygen and AA limits the oxygen concentration to less than 4.5 
mg/L.
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Figure 8:  Overlay of CV’s for Bare 2.0 mm Au electrode in ACSF 3 
 
 
Figure 9.  Overlay of CVs for Eugenol coated 2.0 mm Au electrode in 0.5 mM Ascorbic 
Acid in ACSF 
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Figure 10.  Dissolved Oxygen Calibration Curves for a Eugenol coated 2.0 mm Au 
electrode in ACSF and in 0.5 mM Ascorbic Acid in ACSF 
 
Conclusions 
 
 This research was successful in showing the benefits of using a polyeugenol coating for 
in-vivo oxygen sensing.  Eugenol only electropolymerizes onto the Au electrode surface, 
eliminating the “trapped” oxygen effect observed in the Nafion® coating.  Eugenol also displays 
no signs of degradation after repeated use in ACSF, it actually seems to become more sensitive 
to oxygen detection.  RCA-1 cleaning will also result in a uniform coating that is still sensitive to 
oxygen and impermeable to large molecules like RuHex.  The eugenol coating is also sufficient 
for use in ascorbic acid in ACSF because it will not foul like a bare Au electrode will.  Overall it 
appears that a polyeugenol coated electrode is a promising option for in-vivo chemical sensors.  
Future work could include repeating the degradation experiments with a Nafion® coated Au 
electrode to see if it also becomes more sensitive to oxygen after exposure to ACSF. 
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Analysis of Plasma Polymerized Acetylene Films on Silicon Chips by Fourier 
Transform Mass Spectrometry 
Scott Robotham, Nebraska Wesleyan University 
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Abstract 
 
Positive and negative ion mode laser desorption/ionization-Fourier transform mass 
spectrometry was used to analyze the films formed by plasma polymerization of acetylene 
on silicon chips. From the three films discussed here, it can be seen that a bipolar discharge 
method of plasma polymerization results in a much larger relative number of hydrocarbon 
oligomers in the film compared to unipolar discharge and continuous discharge methods. 
All films showed carbon cluster formation. It was also discovered that in the increasing of 
the thickness of the film leads to a broader mass range spectrum.         
 
Introduction 
  
Since its invention in 1974,1 Fourier transform mass spectrometry (FTMS) has become 
known as one of the most powerful forms of instrumentation in the field of analytical chemistry.2  
FTMS offers superior resolving power and mass accuracy; the reason is the use of the ion 
cyclotron resonance (ICR) cell as mass analyzer. The ICR cell is usually a box or a cyclinder 
using three pairs of electrodes. The pair perpendicular to magnetic field is used to trap the ions. 
Once inside the cell, ions are excited to stable cyclotron orbits by a short on resonance radio 
frequency (rf) pulse, produced by two opposing ICR cell electrodes positioned parallel to 
magnetic field. The ion motion in cyclotron orbit is defined by ion cyclotron frequency which 
depends on m/z of the ion and the magnetic field strength. This frequency is detected by the two 
remaining electrodes and displayed as a time domain spectrum. The time domain spectrum can 
be Fourier transformed to yield a frequency spectrum that can be displayed as an m/z spectrum.3  
The unmatched mass accuracy and resolving power makes it possible to determine the difference 
between isobars. Isobars are signals of ions that have the same nominal mass but differ in 
fractional mass. The ability of FTMS to distinguish this difference makes it possible to analyze 
and identify compounds and mixtures that were impossible to study before.  
  
Molecules have to be in charged or ionized form in order to be analyzed. One of the most 
widely used ionization methods is to use a laser to create the ions from the sample - a method 
called laser desorption/ionization (LDI), and it was commonly done using a pulsed CO2 IR 
laser.4,5 LDI is very effective for ionizing, and vaporizing smaller particles, however when 
molecules are too large it becomes ineffective at creating molecular ions. This problem was 
solved by the discovery of matrix assisted laser desorption/ionization (MALDI). MALDI uses an 
ultraviolet laser, rather than a CO2 laser for desorption. In MALDI, the sample is premixed with 
an excess of an ultraviolet (UV) light adsorbing molecule, the matrix.  The matrix efficiently 
absorbs and transfers the UV laser light and thus the ionization energy to the analyte.6-8 Using 
this method it is possible to ionize particles as large as 1.5 million Daltons.9  
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Desorption/ionization on porous silicon (DIOS) is a novel LDI method that uses silicon 
to enhance the analyte ionization. It has been found that silicon behaves as a UV matrix, 
producing softer ionization and increasing the signal to noise ratio of mass spectrum relative to 
more common MALDI matrices.10,11  
 
Plasma polymerization is one of the newest techniques in polymer synthesis. It can be 
used to form a thin film polymer layer that can range from 10 nm to 1 µm in thickness. Such 
films have many different uses such as protective coatings, electronics, permselective 
membranes, and biomedical materials.12,13 The plasma polymerization of acetylene on silicon 
chips has recently been a process that has attracted the interest of many researchers around the 
world. There have been several papers that have discussed in detail the type of reactants found in 
the plasma by IR absorption and mass spectrometry analysis.14 However, to our knowledge, there 
has never been analytical analysis of the film formed on the silicon wafer. 
 
In the following research, Fourier transform mass spectrometry has been used to identify 
the products formed by plasma polymerization of acetylene on silicon chips. Three chips are 
analyzed in this report. Each chip was formed using a different discharge method, one with 
unipolar, one with bipolar, and the last one with continuous discharge. Both positive and 
negative DOIS-FTMS spectra were collected. The analysis indicates a difference in the acetylene 
products of constituting each film.   
 
Experimental Methods 
 
LDI-FTMS was done on an IonSpec/Varian (Lake Forest, CA) with a 9.4 Tesla 
superconducting magnet, and an external ionization source. The system is equipped with a 355 
nm Nd-YAG laser. The ions were guided into the ion cyclotron resonance cell using RF 
quadrupole ion optics. The spectra were acquired in both positive and negative ion modes at a 
pressure of ~3x10-10 Torr.  Each spectrum was a result of 6 laser pulses. For each laser pulse the 
quadrupole settings were adjusted in order to guide a different mass range in the sample. This 
allowed us to achieve a final spectrum that had a broad mass range from 300 to 5000 m/z.15  
 
Each sample was given a code which was assigned by listing the date which it was made, 
and also a letter to indicate which came first in that day. The samples analyzed in this report 
were the following: for the unipolar discharge 080225A; for the bipolar discharge 071128F; and 
for the continuous discharge 080602B. 
 
Results and Discussion 
 
Each film was analyzed in both the positive and negative ion mode as mentioned above. 
Also for each spectrum the Mn, Mw, and the polydispersity (PD) was calculated using the 
following equations: 
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where M is mass of peak of i and R is the relative abundance of peak i.16  
  
The unipolar discharge film (080225A) showed only carbon clusters, with m/z ranging 
from 720 to 2040 in the positive ion mode (Fig. 1A). The average resolving power was ~42,000, 
with Mn = 1438, Mw = 1504, and PD= 1.05 found using Eq. 1-3. In the negative ion mode, the 
spectrum had peaks with an m/z range of 552 to 1954, and showed both hydrocarbon oligomers 
and carbon clusters (Fig. 1B). The average resolving power was ~37,000 and Mn = 1361, Mw = 
1421, and PD= 1.04. 
  
The bipolar discharge (071128F) film had an m/z range from 505 to1873, and showed 
both hydrocarbon oligomers and carbon clusters (Fig. 2A). The average resolving power was 
~8,000, with Mn = 1119, Mw = 1211, and PD= 1.08. The negative ion spectrum had hydrocarbon 
oligomers and carbon clusters with an m/z range of 779 to1969 (Fig. 2B). This spectrum had an 
average resolving power of ~23,000 and Mn = 1354, Mw = 1407, and PD= 1.04. 
  
For the continuous discharge film (080602B) the positive ion spectrum showed a small 
amount of hydrocarbon oligomers and carbon clusters,  however there are two different m/z 
distributions in the spectrum that span an m/z range of 720 to 4584 (Fig. 3A). The average 
resolving power of the spectrum was ~18,000. For this spectrum two separate sets of Mn, Mw, 
and PD values were taken.  For the first distribution the values are Mn = 1543, Mw = 1660, and 
PD= 1.08, and for the second distribution Mn = 3757, Mw = 3813, and PD= 1.01. The negative 
ion mode spectrum also had very wide distribution of carbon clusters with a m/z range from 520 
to 4320.  There were also a few hydrocarbon oligomers in the lower mass ranges (Fig. 3B).  For 
the negative mode the average resolving power was ~27,000 with once again two sets of Mn, 
Mw, and PD values. The first set was Mn = 1313, Mw = 1530, and PD= 1.16, and the second set 
of values was Mn = 3745, Mw = 3780, and PD= 1.01. 
  
In the positive ion mode, spectra carbon clusters are clearly the most abundant 
component of the sample. These clusters are very stable, and also differ from one another by two 
carbons. In all positive spectra C60 and C70 are found in relatively high abundance because of 
their stability as positive ions. It has been reported that in LDI of hydrocarbon samples tend to 
form carbon clusters.17  However, we believe that carbon clusters are not formed by LDI in film 
samples because a number of film samples did not produce carbon cluster signals in FTMS 
spectra (data not shown). In order to completely determine if carbon clusters are formed on the 
silicon chips X-ray photoelectron spectroscopy should be performed.  
  
The negative ion mode spectra also show carbon clusters as more abundant, however 
there is a much greater number of hydrocarbons present. In these spectra, the unmatched 
resolving power of FTMS is necessary in assigning of the isobars (Fig 4). These hydrocarbons 
have a much higher number of carbons then hydrogens in the structures, and the oligomers show 
a pattern of having either an even number of carbons and hydrogens, or an odd number of both 
carbons and hydrogens. There are no signals found in any sample that have even number of 
carbons and an odd number of hydrogens, or an odd number of carbons and an even number of 
hydrogens. The reason that this pattern is present in the oligomers is still unclear; further 
research is needed in order to determine the answer to this problem. 
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 The bipolar discharge film (071128F) showed a much higher abundance of hydrocarbon 
oligomers then any of the other films (Fig. 5C and D). These oligomers were even found in fairly 
high abundance in the positive ion mode spectrum. The results indicate that bipolar discharge 
leads to a much greater formation of hydrocarbon oligomers in the plasma polymerization. 
 
The continuous discharge film (080602B) shows a much broader mass range then the 
other two films because the thickness of this film is approximately 3x thicker then the all of the 
other films. The continuous discharge film also shows a small number of hydrocarbon signals 
compared to that of the bipolar discharge method (Fig. 5B), indicating that the continuous 
discharge during plasma polymerization results in a much greater formation of carbon clusters. 
 
The unipolar discharge film (080225A) negative ion mode spectra also shows far less 
hydrocarbon formation compared to that of the bipolar discharge film, but is similar to the 
continuous discharge film (Fig. 5A). The difference between the continuous discharge and the 
unipolar discharge negative ion spectra is that the continuous discharge spectrum has a much 
broader mass range for the carbon clusters, and also hydrocarbons are spread out over two 
distributions whereas in the unipolar spectrum there is only one distribution.   
 
Conclusion 
  
A strategy for performing positive and negative ion mode LDI-FTMS analysis of plasma 
polymerized acetylene on silicon chips has been described. The results of this analysis show the 
presence of carbon clusters and hydrocarbon oligomers in different amounts. It is clear from the 
spectra that bipolar method of plasma polymerization forms a greater amount of hydrocarbon 
oligomers compared to that of unipolar and continuous discharge. It can also be seen that if the 
thickness of the film is increased this leads to a broader mass range in the spectrum.     
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Appendix
Figure 1.LDI-FTMS spectra of Unipolar Discharge Film: a) positive ion mode, b) negative ion 
mode. Insets are showing partial spectrum with assignments of the most abundant peaks with 
calculated molecular weights and average resolving power 
A
B
85 
 
 
Figure 2. LDI-FTMS spectra of Bipolar Discharge Film: a) positive ion mode, b) negative ion 
mode. Insets are showing partial spectrum with assignments of the most abundant peaks with 
calculated molecular weights and average resolving power  
 
 
 
 
 
 
 
 
A 
B 
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Figure 3. LDI-FTMS spectra of Continuous Discharge Film: a) positive ion mode, b) negative 
ion mode. Insets are showing partial spectrum with assignments of the most abundant peaks with 
calculated molecular weights and average resolving power 
A
B
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Figure 4. Inset of LDI-FTMS spectrum of Bipolar Discharge Film with assignments of four 
isobars (average error = 1.7 ppm)
C108
(13C) C105 
(13C) C107 
C106 H24
88
Figure 5. Plots of number of hydrogen versus number of carbons in hydrocarbon oligomers. 
Spectra that produced only carbon clusters are not plotted.  
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Racemization of Chiral Lithium Carbanions:  An Exercise in Organic 
Synthesis, Analytical Chemistry, Solution Kinetics, and Chemical 
Thermodynamics 
Andrew Ward, University of Detroit Mercy 
Detroit, MI 
 
Abstract 
 
Chiral lithium carbanions are key intermediates in the synthesis of natural products and 
pharmaceuticals since they are easily generated using a chiral base and they can retain 
their structural integrity.  The objective of this research is to study the rate of racemization 
for these chiral carbanion molecules both in the presence and absence of diamine ligands.  
The molecules were synthesized and then analyzed with GC-MS, and 13C NMR and 1H 
NMR.  The molecules were purified for experiments using CSP-SFC analysis. 
 
Introduction 
 
 The study of chirality in various organic molecules is of the utmost importance to the 
pharmaceutical industry and the world at large.  The proteins and carbohydrates in all living 
organisms are chiral.  Naturally occurring proteins are all derived from S-amino acids while 
carbohydrates are all derived from R-sugars.  It is thusly evident why the synthesis and research 
of chiral molecules is a large focus for the pharmaceutical industry.  In many cases, only one of 
the enantiomers of a chiral molecule is pharmacologically active.  The other enantiomer could be 
pharmacologically inactive and, in the worst cases, highly toxic to the receiver of the drug.  One 
such case of the industry marketing the wrong enantiomer as the active drug involved the drug 
thalidomide.  The racemate acted as a sedative for women with morning sickness whereas the R-
enantiomer alone acted as a teratogen.  Since the molecule racemizes in vivo, the R-enantiomer 
of thalidomide caused the women who took it to give birth to seriously deformed children.   
 
N
O
O
N
H
O
O
 
 
Fig. 1. Racemic structure of thalidomide. 
 
 Chiral lithium carbanions are imperative to pharmaceutical companies for the synthesis 
of natural products.1,2  These intermediates can be easily generated using chiral bases and retain 
their structural integrity at low temperatures.3-5  Quenching the carbanion with an electrophile 
allows for the generation of a new chiral center at the point of lithiation.6-8  In this project, the 
interest is in the rate at which the chiral carbanions racemize both in the presence and absence of 
diamine ligands.  The carbanion studied is 2-Li-N-Boc-piperidine (2) which is generated by 
Sn/Li exchange from the corresponding stannane (1) as show in Figure 2.  The generation of 
piperidine-based stannanes and silanes, as well as diamine ligands, is vital to the next steps of the 
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research project, namely the kinetics and thermodynamics resolution studies.   
 
N
Boc
SnBu3
n-BuLi
ether N
Boc
Li
+ SnBu4
ligand
N
Boc
Li*ligand
+
N
Boc
Li*ligand
 
(1)                                            (2)                                               (3)                                  (4)                
 
Fig. 2.  Sn/Li exchange with complexation of ligand to the racemic lithiated carbon atom. 
 
The corresponding studies with the analogous N-Boc-pyrolidine and N-trimethylallyl-pyrolidine 
systems have already been completed.9,10 
 
Experimental Details 
 
1.  Synthesis of N-Boc-Piperidine 
 
N
H
(Boc)2O (0.12 mol)
CHCl3 N
Boc  
 
                                                       (5)                                     (6) 
 
To a 250 mL round bottom flask, 100 mL of CHCl3 and 26.2 g (0.12 mol) of t-Butoxycarbonate 
were added.  9.88 mL (0.1 mol) of piperidine (5) were added to the round bottom flask that was 
attached to the addition funnel.  The solution was then added dropwise over three hours while 
stirring.  Afterwards, the organics were washed with water three times and dried over magnesium 
sulfate.  Then, the CHCl3 solvent was removed on the rotary evaporator to afford product (20.4 
g; 0.12 mol; 100% yield).  The product (6) was vacuum dried in the hood prior to use in order to 
remove excess solvent and stored with a piece of CaH2. 
 
2.  Synthesis of N-Boc-piperidne 
 
N
H
(Boc)2O (0.1 mol)
CHCl3 N
Boc  
 
                        (5)                                     (6) 
 
To a 250 mL round bottom flask, 100 mL of CHCl3 and 21.8 g (0.1 mol) of t-Butoxycarbonate 
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were added.  9.88 mL (0.1 mol) of piperidine (5) were added to the round bottom flask that was 
attached to the addition funnel.  The solution was then added dropwise over three hours while 
stirring.  Afterwards, the organics were washed with water three times and dried over magnesium 
sulfate.  Then, the CHCl3 solvent was removed on the rotary evaporator to afford product (18.5 
g; 0.1 mol; 100% yield).  The product (6) was vacuum dried in the hood prior to use in order to 
remove excess solvent and stored with a piece of CaH2. 
 
3.  Synthesis of 2-(trimethylsilyl)-N-Boc-piperidine  
 
N
Boc
secBuLi (0.03 mol)
TMEDA (0.03 mol)
50 mL ether
-80 
0
C
3 hrs
N
Boc
Li
Bu3SnCl (0.03 mol)
-80 
0
C -> rt, overnight N
Boc
SiMe3
 
 
                (6)                                            (2)                                                      (7) 
 
A 250 mL round bottom flask was dried in the oven and then cooled in the desiccator to remove 
all moisture.  A septum was put on top of the cooled flask.  Through the septum, 50 mL ether, 
1.9 mL (0.01 mol) of N-Boc-piperidine (6), and 4.5 mL (0.03 mol) of TMEDA were added by 
syringe.  The reaction flask was cooled to -80 0C under argon pressure.  21 mL (0.03 mol) of sec-
BuLi was added slowly to the side of the flask.  The reaction was left stirring at this temperature 
for three hours.  3.8 mL (0.03 mol) of Me3SiCl was slowly added to the reaction, which was then 
allowed to come to room temperature overnight.  Afterwards, 100 mL of deionized water was 
added to the reaction to dissolve the precipitate of LiCl.  The organics were washed with 100 mL 
of ether, dried over magnesium sulfate, and the solvent was removed on the rotary evaporator.  
The product (7) was purified by column chromatography with 98% hexanes: 2% ethyl acetate as 
the mobile phase.  
 
4.  Synthesis of 2-(trimethylstannyl)-N-Boc-piperidine  
 
N
Boc
secBuLi (0.03 mol)
TMEDA (0.03 mol)
50 mL ether
-80 
0
C
3 hrs
N
Boc
Li
Bu3SnCl (0.03 mol)
-80 
0
C -> rt, overnight N
Boc
SnBu3
 
 
     (6)                                            (2)                                                    (1) 
 
A 250 mL round bottom flask was dried in the oven and then cooled in the desiccator to remove 
all moisture.  A septum was put on top of the cooled flask.  Through the septum, 50 mL ether, 
1.9 mL (0.01 mol) of N-Boc-piperidine (6), and 4.5 mL (0.03 mol) of TMEDA were added by 
syringe.  The reaction flask was cooled to -80 0C under argon pressure.  21 mL (0.03 mol) of sec-
BuLi was added slowly to the side of the flask.  The reaction was left stirring at this temperature 
for three hours.  8.1 mL (0.03 mol) of Bu3SnCl was slowly added to the reaction, which was then 
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allowed to come to room temperature overnight.  Afterwards, 50 mL of 2M HCl was added to 
the reaction to dissolve the precipitate of LiCl.  The organics were washed with 100 mL of ether, 
dried over magnesium sulfate, and the solvent was removed on the rotary evaporator.  The 
product (1) was purified by column chromatography with hexanes as the mobile solvent. 
 
5.  Synthesis of 2-(trimethylstannyl)-N-Boc-piperidine  
 
N
Boc
secBuLi (0.03 mol)
TMEDA (0.03 mol)
50 mL ether
-80 
0
C
3 hrs
N
Boc
Li
Bu3SnCl (0.03 mol)
-80 
0
C -> rt, overnight N
Boc
SnBu3
 
 
    (6)                                                 (2)                                                            (1) 
 
A 250 mL round bottom flask was dried in the oven and then cooled in the desiccator to remove 
all moisture.  A septum was put on top of the cooled flask.  Through the septum, 50 mL ether, 
1.9 mL (0.01 mol) of N-Boc-piperidine (6), and 4.5 mL (0.03 mol) of TMEDA were added by 
syringe.  The reaction flask was cooled to -80 0C under argon pressure.  21 mL (0.03 mol) of sec-
BuLi was added slowly to the side of the flask.  The reaction was left stirring at this temperature 
for three hours.  8.1 mL (0.03 mol) of Bu3SnCl was slowly added to the reaction, which was then 
allowed to come to room temperature overnight.  Afterwards, 50 mL of 2M HCl was added to 
the reaction to dissolve the precipitate of LiCl.  The organics were washed with 100 mL of ether, 
dried over magnesium sulfate, and the solvent was removed on the rotary evaporator.  The 
product (1) was purified by column chromatography with hexanes as the mobile solvent. 
 
6.  Synthesis of N-Boc-piperidine 
 
N
H
(Boc)2O (0.1 mol)
CHCl3 N
Boc  
 
           (5)                                          (6) 
 
To a 250 mL round bottom flask, 100 mL of CHCl3 and 21.8 g (0.1 mol) of t-Butoxycarbonate 
were added.  9.88 mL (0.1 mol) of piperidine (5) were added to the round bottom flask that was 
attached to the addition funnel.  The solution was then added dropwise over three hours while 
stirring.  Afterwards, the organics were washed with water three times and dried over magnesium 
sulfate.  Then, the CHCl3 solvent was removed on the rotary evaporator to afford product (18.5 
g; 0.1 mol; 100% yield).  The product (6) was vacuum dried in the hood prior to use in order to 
remove excess solvent and stored with a piece of CaH2. 
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7.  Synthesis of N-Boc-piperidine 
 
N
H
(Boc)2O (0.1 mol)
CHCl3 N
Boc  
 
                                                      (5)                                      (6) 
 
To a 250 mL round bottom flask, 100 mL of CHCl3 and 21.8 g (0.1 mol) of t-Butoxycarbonate 
were added.  14.8 mL (0.15 mol) of piperidine (5) were added to the round bottom flask that was 
attached to the addition funnel.  The solution was then added dropwise over three hours while 
stirring.  Afterwards, the organics were washed with water three times and dried over magnesium 
sulfate.  Then, the CHCl3 solvent was removed on the rotary evaporator to afford product (18.5 
g; 0.1 mol; 100% yield).  The product (6) was vacuum dried in the hood prior to use in order to 
remove excess solvent and stored with a piece of CaH2. 
 
8.  Coupling of Boc-L-proline and L-proline methyl ester 
 
N
Boc
CO2H
+ NH
CO2Me
EDCI/HOBT
Et3N/CHCl3
RT, overnight N
Boc
O
N
MeO2C  
 
                          (8)                          (9)                        (10) 
 
0.595 g (2.8 mmol) of Boc-L-proline (8) was dissolved in15 mL of CHCl3 in a 250 mL round 
bottom flask.  To this solution, 0.538 g (2.8 mmol) of EDCI and 0.43 g (2.8 mmol) of HOBT 
were added.  The suspension was stirred for 10 min.  0.463 g (2.8 mmol) of L-proline methyl 
ester (9) were dissolved in 3 mL Et3N/ 10 mL CHCl3 and then added to the reaction mixture.  
The mixture was stirred overnight.  Afterwards, all solvents were removed with the use of a 
rotovap.  Then, 100 mL of ethyl acetate was added and the mixture was stirred.  The solid 
residues were removed by gravity filtration.  The solution was then washed twice with 50 mL 
10% citric acid and four times with 25 mL of 10% NaHCO3 solution.  The extracted product 
(10) was dried over Na2SO4 and the solvents were removed in vacuo to obtain a pale yellow oil. 
 
 
 
 
 
 
 
 
 
94 
 
9.  Coupling of Boc-L-proline and L-proline methyl ester 
 
N
Boc
CO2H
+ NH
CO2Me
EDCI/HOBT
Et3N/CHCl3
RT, overnight N
Boc
O
N
MeO2C  
 
                         (8)                           (9)                                                        (10) 
 
 
3.225 g (0.015 mol) of Boc-L-proline (8) was dissolved in 30 mL of CHCl3 in a 250 mL round 
bottom flask.  To this solution, 2.325 g (0.015 mol) of EDCI and 2.027 g (0.015 mol) of HOBT 
were added.  The suspension was stirred for 10 min.  1.903 g (0.015 mol) of L-proline methyl 
ester (9) were dissolved in 3 mL Et3N/ 10 mL CHCl3 and then added to the reaction mixture.  
The mixture was stirred overnight.  Afterwards, all solvents were removed with the use of a 
rotovap.  Then, 100 mL of ethyl acetate was added and the mixture was stirred.  The solid 
residues were removed by gravity filtration.  The solution was then washed twice with 50 mL 
10% citric acid and four times with 25 mL of 10% NaHCO3 solution.  The extracted product 
(10) was dried over Na2SO4 and the solvents were removed in vacuo to obtain a pale yellow oil. 
 
10.  Synthesis of N-Boc-piperidine 
N
H
(Boc)2O (0.1 mol)
CHCl3 N
Boc  
 
                          (5)                                       (6) 
 
To a 250 mL round bottom flask, 100 mL of CHCl3 and 21.8 g (0.1 mol) of t-Butoxycarbonate 
were added.  14.8 mL (0.15 mol) of piperidine (5) were added to the round bottom flask that was 
attached to the addition funnel.  The solution was then added dropwise over three hours while 
stirring.  Afterwards, the organics were washed with water three times and dried over magnesium 
sulfate.  Then, the CHCl3 solvent was removed on the rotary evaporator to afford product (18.5 
g; 0.1 mol; 100% yield).  The product (6) was vacuum dried in the hood prior to use in order to 
remove excess solvent and stored with a piece of CaH2. 
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11.  Synthesis of 2-(trimethylsilyl)-N-Boc-piperidine  
 
N
Boc
secBuLi (0.03 mol)
TMEDA (0.03 mol)
50 mL ether
-80 
0
C
3 hrs
N
Boc
Li
Bu3SnCl (0.03 mol)
-80 
0
C -> rt, overnight N
Boc
SiMe3
 
 
                (6)         (2)         (7) 
 
A 250 mL round bottom flask was dried in the oven and then cooled in the desiccator to remove 
all moisture.  A septum was put on top of the cooled flask.  Through the septum, 100 mL ether, 
3.8 mL (0.02 mol) of N-Boc-piperidine (6), and 9 mL (0.06 mol) of TMEDA were added by 
syringe.  The reaction flask was cooled to -80 0C under argon pressure.  42 mL (0.06 mol) of sec-
BuLi was added slowly to the side of the flask.  The reaction was left stirring at this temperature 
for three hours.  7.6 mL (0.06 mol) of Me3SiCl was slowly added to the reaction, which was then 
allowed to come to room temperature overnight.  Afterwards, 100 mL of 10% KF solution was 
added to the reaction to dissolve the precipitate of LiCl.  The organics were washed with 100 mL 
of ether, dried over magnesium sulfate, and the solvent was removed on the rotary evaporator.  
The product (7) was purified by column chromatography with 98% hexanes: 2% ethyl acetate as 
the mobile phase.  
 
12.  Synthesis of (S,S)-Val-pro 
 
 
N
CH3
Boc
CH3CH3
CO2H
+
(11)
NH
MeO2C
(12)
EDCI/HOBT
Et3N/CHCl3
RT, ON
N
CH3
Boc
CH3CH3
O
N
CO2Me
(13)
LiAlH4/THF reflux, ON
N
CH3
CH3
CH3CH3
N
CH2OH
(14)  
 
 
a.  Synthesis of (13) 
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3.47 g (0.015 mol) N-Boc-valine (11) was dissolved in 30 mL CHCl3 in a 250 mL round bottom 
flask.  2.86 g (0.015 mol) of EDCI and 2.03 g (0.015 mol) of HOBT were added to the reaction 
flask and the suspension was stirred for 10 min.  1.94 g (0.015 mol) of L-proline methyl ester 
(12) was dissolved in 3 mL Et3N/10 mL CHCl3.  The solution was added to the reaction flask.  
The reaction was stirred overnight.  Afterwards, the solvents were removed with the rotovap to 
obtain a pale yellow color.  150 mL of ethyl acetate were added and the mixture was stirred.  The 
product was gravity filtered to remove solvents.  The solution was washed twice with 50 mL of 
10% citric acid, and then four times with 25 mL 10% NaHCO3.  It was then dried over solid 
Na2SO4 and the solvents were removed in vacuo to obtain a white solid. 
 
b.  Reduction of (13) 
 
2.0 g of LiAlH4 were cooled in 15 mL of THF in a 100 mL round bottom flask to –5 C using the 
cooling unit.  The amide (13) was dissolved in 20 mL THF and slowly added dropwise to the 
stirred suspension.  The mixture was stirred for 10 min at rt, and then heated at reflux overnight 
in an oil bath.  Afterwards, the mixture was cooled to rt and then to –5 C.  Slowly, 50 mL of 2M 
NaOH were added to the reaction via a dropping funnel making sure that the flasks did not touch 
to allow for escape of gases.  The reaction was gravity filtered with a Buchner funnel to remove 
the solid which was then washed with 100 mL of ether.  The wash and the filtrate were combined 
and extracted twice with 100 mL ether.  The ether layer was concentrated to 50 mL in vacuo.  
The product was extracted twice with 100 mL 2M HCl.  The protonated amine became soluble in 
the aqueous layer which was washed with ether.  The solution was basified with 50% KOH via a 
dropping funnel until pH 14 was obtained and the solution turned cloudy.  It was extracted twice 
with 50 mL ether and the solvents were removed in vacuo. 
 
Results and Discussion 
 
The N-Boc-piperidine (6) and the silane compound (7) were characterized by GC-MS 
while the stannanes were characterized by 119Sn NMR.  The peptide compounds were analyzed 
by 13C NMR.  These analytical techniques proved that the desired compounds detailed above 
were successfully synthesized.  Chemical purity is very important for the next steps of the 
research which are the kinetic and thermodynamic studies.  It was made sure that there was no 
moisture stored with any of the products. 
 
The GC-MS results showed that (6) was successfully generated:  6.373 min [M+] 185 
m/z.  Also, the GC-MS proved that (7) was synthesiszed:  11.024 min [M+71]+ 258 m/z. 
 
The 13C NMR results showed that (10) was successfully generated.  13C NMR (C6D6, δ):  
173, 172, 155, 79, 59, 58, 51, 46, 45, 29, 28, 25, 24, and 23.  The 13C NMR also proved that (13) 
was also successfully synthesized.  13C NMR (C6D6, δ):  73 (CH), 68 (CH2), 64 (CH), 59 (CH2), 
54 (CH2), 40 (CH3), 30 (CH2), 25 (CH2), 24 (CH), and 23 (CH3). 
 
The 119Sn NMR showed that the stannane (1) was successfully synthesized.  119Sn NMR:  
δ 155 (C4), 79 (C4), 45 (CH2), 38 (CH), 32 (CH2), 31 (CH2), 30 (CH2), 29 (CH3), 28 (CH2), 21 
(CH2), 13 (CH3), and 12 (CH2). 
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Conclusion 
 
 The synthesis of the desired chiral compounds needed for the kinetic and thermodynamic 
resolution studies is an essential part of the research project.  Great attention to the purity of each 
sample must be taken in order to obtain positive results.  The generation of a large amount of the 
piperidine-based stannanes and silanes has been mostly successful over the summer.  Products 
were purified and isolated from excess starting material and other compounds.  These 
compounds were then ready to pass on to the next phase of the research. 
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Background
Fibroblast Growth Factors (FGFs) play a significant roles in the regulation of cell proliferation,
angiogenesis, differentiation, tumor formation, embryonic growth, invasion, inflammation, and
tissue repair. To date, at least 23 FGFs have been discovered, named consecutively from FGF-1 to
FGF-23. FGFs are about 154 amino acids long and share a common core of 140 amino acids, of
which 28 residues are highly conserved and 6 residues are invariant. FGFs are all beta-barrel
proteins and contain no disulfide bonds.
Studies indicate that FGFs produce biological responses by binding to two types of receptors on the
cell surface. The first class is a high affinity family of transmembrane tyrosine kinase receptors
called FGFRs. The binding of FGFs to the tyrosine kinase receptors plays an essential role in
biological activation of FGFs. The prototype FGFR structure consists of an extracellular region, a
transmembrane helix domain, and an intracellular tyrosine kinase domain. Binding of FGF to FGFR
leads to receptor dimerization and subsequent tyrosine autophosphorylation and phosphorylation of
target molecules, which initiates a phosphorylation cascade within the cell that culminates in
multiple cellular outcomes.
The second class of receptors is the family of heparan sulfate proteoglycans (HSPGs), which have a
low affinity for FGFs. HSPGs are polymers of disaccharide repeats, which are highly sulfated and
negatively charged. HSPGs are found in the extracellular matrix adjacent to cell surfaces and as
integral components of the plasma membrane. The absence of HSPGs on cell surfaces reduces FGF
oligomerization, which affects FGF binding to FGFR(s) and lowers FGFR activity. The interaction
of heparin with FGFs stabilizes the protein against thermal denaturation, proteolysis, FGF release
into interstitial spaces and limits diffusion. Binding also increases mitogenesis and wound healing.
Additionally, heparin helps to increase the affinity and half-life of the FGF-FGFR complex, which
is crucial for signal transduction. Sucrose octasulfate (SOS) is a heparin analog that has been shown
to mimic heparin action and FGF activation. Residues involved in heparin binding correspond to
amino acids 126 to 142 of the human FGF-1 sequence. In this context, we examined the structural
and functional consequences of insertion of additional lysine residues in the heparin binding pocket.
The results clearly indicate that the introduction of lysine residues at positions N128, Y139 and
Q141 in the heparin-binding pocket significantly increases affinity to sucrose octasulfate.
Methods
 Single point mutations were introduced by QuikChange XL Site-Directed
Mutagenesis Kit from Stratagene.
Double point mutation was introduced by overlap extension.
Wild type, N128K, Y139K, Q141K, and N128K/Y139K mutants of hFGF-1
were purified by heparin-affinity chromatography.
 Thermal, urea, and guanidine hydrochloride denaturation experiments of
wild type hFGF-1 and the designed mutants were monitored by steady-state
fluorescence.
 Differential scanning calorimetric experiments were performed using a
Nano III DSC (Calorimetry Sciences Corp.)
 Heparin/SOS binding affinity experiments were carried out using a VP-
Isothermal titration calorimetric instrument.
 Limited trypsin digestion of wild type and mutants of hFGF-1 were
monitored using SDS-PAGE gel electrophoresis.
 SOS binding site(s) were characterized using 2D hetero-nuclear NMR
spectroscopy.
Structure of hFGF-1 Depicting the Heparin-Binding Pocket
hFGF-1         - KKNGSCKRG - - PRTHYGQKAIL-
hFGF-2          -KRTGQYKLG - - SKTGPGQKAIL-
hFGF-3          -NGKGRPRRG - - FKTRRTQKSSL-
hFGF-4          -SKNGKTKKG - - NRVSPTMKVT-
hFGF-5          -NKRGKAKRG - - PRVKP-QHIST-
hFGF-6          -SKYGRVKRG - - SKVSPIMTVT-
hFGF-7          -NQKGIPVRG - - KKTKKEQKTA-
hFGF-8          -TRKGRPRKG - - SKTRQHQREV
hFGF-9          -NKDGTPREG - - TRTKRHQKFT-
hFGF-10         -NGKGAPRRG - - QKTRRKNTSA-
hFGF-11         -DKEGQVMKG - - NRVKKTKAAA-
hFGF-12         -NKEGQIMKG - - NHVKKNKPAA-
hFGF-13         -NKEGEIMKG - - NHVKKNKPAA-
hFGF-14         -NKEGQAMKG - - NRVKKTKPAA-
hFGF-15         -FHRSFFETGD - - LRSK - - - - - -
hFGF-16         -NKDGSPREG - - YRTKRHQKFT
hFGF-17         -TRQGRPRQA - - SRSRQNQREA
hFGF-18         -TKKGRPRKG - - TRENQQDVHF
hFGF-19         -SSAKQRQLY - - RGFLPLSHEFL
hFGF-20         -SNIYKHGDT - - RYFYALNKDG 
hFGF-21        -HRDPAPRGP - - ARFLPLPGLPPA
hFGF-22        -GRTNYHLSA - - HFLPVLVS - - - -
hFGF-23        -PYSQFLSRR - - IPLIHFNTPIPRRHMolMol representation of hFGF-1. Putative heparin binding site(s) are
shown in green. The heparin binding region is mostly located in beta
strand XI, the loop between strands X and XI and the loop between
strands XI and XII.
N128
Y139
Q141
Amino acid sequence of the predicted heparin binding
pocket in various isoforms of hFGFs. Mutations
designed in hFGF-1 are indicated in red.
Stability Monitored by Fluorescence Spectroscopy
FGF-1-WT- Tm= 44.7 C
FGF-1-WT+SOS- Tm= 50.1 C
N128K/Y139K- Tm= 42.6 C
N128K/Y139K+SOS-Tm= 53.8 C
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Panels A, B, and C represent the equilibrium unfolding of the wild type hFGF-1 and the
N128K/Y139K double mutant of hFGF-1 in absence and presence of SOS, induced by thermal,
guanidine hydrochloride, and urea, respectively. The denaturation were monitored by steady-state
fluorescence at 350 nm. The binding of SOS provides additional stability to the double mutant as
compared to the wild type hFGF-1.
Conclusions
 Several hFGF-1 mutants with additional lysine residues in the heparin binding pocket have
been successfully generated, expressed and purified.
 Incorporation of additional lysine residues increases the heparin-binding affinity of hFGF-1.
 The thermodynamic stability of the double mutant (N128K/Y139K) of hFGF-1 increases
significantly upon binding to SOS.
 The backbone conformation of the double mutant is similar to wild type hFGF-1.
 SOS appears to bind to the positively charged residues in the heparin binding pocket.
SOS Binding Affinity
ITC curves showing the binding of SOS/heparin to wild type and mutants of hFGF-1 at 25 C. The
upper panels show the raw data representing hFGF-1 – SOS titration. The bottom panels show the
integrated data obtained from the raw data after background subtraction. The solid line in the
bottom panels represent the best-fit curve of the experimental data, using the one site and sequential
binding site(s) model from Microcal Origin.
Stability Monitored by DSC
Differential scanning calorimetry thermograms representing the unfolding of wild type and mutants
of hFGF-1. The protein (0.5 mg/mL) was dissolved in 10 mM phosphate buffer (pH 7.2) containing
100 mM NaCl and 50 mM ammonium sulfate. Thermograms were corrected for background noise.
The experiments were performed at a scan rate of 1 C/min.
Stability Monitored by Limited Proteolytic Digestion
Time-dependent trypsin digestion of the wild type and N128K/Y139K double mutant of
hFGF-1 in absence and presence of SOS. Lanes 1 through 9 represent the trypsin digestion
products formed after 0 min (lane 1), 15 min (lane 2), 30 min (lane 3), 45 min (lane 4), 60 min
(lane 5), 90 min (lane 6), 120 min (lane 7), 150 min (lane 8) and 180 min (lane 9). Panel B
represents the densitometry scan of the band corresponding to hFGF-1 wild type and the
N128K/Y139K mutant band (~16 kDa). The concentration of the protein and SOS used were
0.05 mM and 0.5 mM, respectively.
Identification of SOS Binding Site(s) on hFGF-1
A B
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Panel A- 1H-15N HSQC spectra of wild type
hFGF-1 obtained in the absence (red) and
presence (green) of SOS. The significant
chemical shift perturbation observed in the
presence of SOS indicates that these residues
are in the vicinity of the SOS site(s). Panel B-
Overlap of the 1H-15N HSQC spectra of
N128K/Y139K double mutant (yellow) and wild
type hFGF-1 (red).
1H-15N chemical shift perturbation of residues in
hFGF-1 in the presence of SOS. The amino acid
residues in hFGF-1 that exhibited significant
chemical shift perturbation and are involved in SOS
binding are indicated by the residue number.
MolMol representation of the structure of hFGF-1
(Blue). Residues which exhibit prominent chemical-
shift perturbation are indicated in green. The
residues constituting the SOS binding site(s) are
mostly located in beta strand XI and the loops
between strands X and XI and strands XI and XII.
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The Enhancement of In Vitro Microdialysis Recovery of      
Interferon-γ Using Affinity Agents
Chris Ladner1, Julie A. Stenken2
1Spring Hill College, 2University of Arkansas, Department of Chemistry and Biochemistry
Microdialysis is a common way to sample small, low molecular weight 
analytes.  In living tissue it has become increasingly important to study small 
signaling proteins called cytokines.  These proteins are vital for cellular 
communication. In vivo, a small microdialysis probe is inserted into the 
tissue.  A buffer solution is perfused through the probe and cytokines diffuse 
through the membrane.  The cytokines are collected though the outlet tube 
(Figure 1).  
One specific cytokine of interest is Interferon-γ (IFN-γ) (Figure 2). 
Interferons are naturally occurring proteins produced by cells of the immune 
system in response to foreign agents, such as viruses.  Specifically, IFN-γ 
activates natural killer cells and macrophages, up-regulates antigen presence 
in lymphocytes, and induces resistance of host cells to viral infection. 
One issue that arises with cytokine microdialysis is a general low 
relative recovery. This is due to several factors including, size and 
conformation of the cytokine, interactions between the cytokine and the 
probe, and flow rate of the perfusion fluid. Affinity agents can increase 
cytokine recovery by changing the concentration gradient (Figure 3).  
Heparin, a naturally occurring glycosaminoglycan, is negatively charged and 
can bind several common cytokines (Figure 4).  Recent studies have shown 
an increase in relative recovery with perfusion fluid containing heparin.  
Cytokine antibodies have also been used to increase relative recovery.
INTRODUCTION
Microdialysis
• For all microdialysis experiments the CMA/20 (10mm) Polyethersulfone (PES) probes with 100kDa 
cut off were used.
• The probes were connected to CMA402 syringe pumps with 1000μL syringes. 
•The buffer for all experiments was the ELISA kit buffer (PBS with 10% FBS, pH 7.0). 
•The probes were immersed in a sample fluid containing 2000 pg/mL IFN-γ. 
• A control was run simultaneously, containing only assay diluent.
• Heparin Sodium Salt was purchased from Sigma-Aldrich. 
• For the Heparin experiments, flow rates of 2μL/min and 1μL/min were used.  The perfusion fluid 
contained 10μM Heparin. 
• For the antibody experiments the ELISA biotinylated anti-rat monoclonal detection antibody was used 
in the perfusion fluid (1.6 nM).  A flow rate of 1μL/min was used. 
ELISA 
•Samples were analyzed using the Rat IFN-γ ELISA kit (BD Biosciences).
•Rat IFN-γ standards from the ELISA kit were used in all experiments. 
•The samples were analyzed with a Tecan Infinite M200 multifunctional microplate reader.
•Fluorescent absorbance (Figure 5) was measured at 450nm and subtracted at 570nm.  
•The Heparin experiment samples were analyzed according to the ELISA protocol by BD Pharmigen.
• The detection antibody samples were analyzed using a modified ELISA procedure. In the modified 
procedure the cytokine samples were prepared and incubated with detection antibody before being 
added to the microwells as opposed to the standard protocol, which requires addition of the antibody 
after the samples have incubated in the microwells.
•Both affinity agents were tested for interference with the ELISA procedure.
MATERIALS AND METHODS
Heparin Samples
Different concentrations of Heparin were added to standard IFN-γ to test for 
interference with the ELISA assay. Heparin concentrations up to 10μM do not interfere 
with the assay (Figure 6). Microdialysis samples with heparin in the perfusion fluid 
were collected at two flow rates and analyzed (Figure 7).  As expected the microdialysis 
yielded a small relative recovery.  The heparin added to the perfusion fluid did not 
appear to increase RR.  This may be due to the binding kinetics of heparin and IFN-γ
Detection Antibody Samples
Detection antibody was also incubated with IFN-γ to test for interference with the 
ELISA assay. Only the twelve hour incubation time appeared to affect the assay (Figure 
8). Microdialysis samples with antibody in the perfusion fluid were collected and 
analyzed (Figure 9).  For the shorter collection time, the antibody sample did not have 
enough cytokine to show absorbance.  The antibody control yielded a similar recovery 
to the heparin control.  At the four hour collection time, the antibody sample did 
increase RR, but not significantly. 
RESULTS
Interferon-γ microdialysis samples were successfully collected using affinity agents. 
Both heparin and the detection antibody do not appear to interference with the ELISA 
procedure, which is used to analyze the samples.  Though they do not interfere, the 
affinity agents do not appear to significantly increase the relative recovery of the IFN-γ.  
Interestingly, the modified ELISA procedure is a viable way to collect and analyze 
cytokines.  In future work different cytokines may be tested with these procedures.  
CONCLUSIONS
NSF-CHE/REU-0552947
Jia Duo, University of Arkansas Department of Chemistry and Biochemistry (Stenken Lab)
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This project aims to study the relative recovery of Interferon-γ using microdialysis.  To this 
end, two known affinity agents, heparin sulfate and  the detection antibody for IFN-γ, were 
used to increase the flow of cytokine into the microdialysis probe.  Dialysate samples were 
collected and analyzed by fluorescent absorbance.
OBJECTIVE
Microdialysis with Heparin
Flow 
Rate
IFN-γ
Buffer
IFNγ
Heparin
2 μL/min 1.31% 1.13%
1 μL/min 1.71% 1.80%
Microdialysis with Antibody
(1 μL/min)
Collection 
Time
IFN-γ
Buffer
IFNγ
Heparin
120 mins 1.88% N.A.
240 mins 0.80% 1.23%
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Figure 1: Schematic of 
microdialysis probe
Figure 2: 3D structure of 
Interferon-γ, ~15.9 kDa.
Figure 4: Chemical and 3D 
structure of heparin. Figure 5: Diagram of ELISA (Enzyme-
Linked ImmunoSorbent Assay) procedure.
Figure 6
Figure 7
Figure 8
Figure 9
Figure 3: The affect of affinity 
agents in the microdialysis probe.
Perfusate
~ 1μL/min
Flow rate
Dialysate
o.d.
200-500 μM
Length  1-30mm WITHOUT Affinity Agent
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Exploratory Hierarchical Nanomachining of New ZnO Tertiary Hetero-Nanostructures 
Sean Nomoto, Andrew Zhou, Z. R. Tian
REU, Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701
Experimental Procedure
• Primary rods were made with HMT, Zn(NO3)3
• Secondary branches made with same materials as Primary rods  with DAP added
• Tertiary structures made by changing  amounts of DAP
Results 
Conclusion
•Rich chemistries involved in the tertiary growth with DAP, most of which are not well understood 
especially at high DAP-concentrations ;
•More work on trends such as time, of reaction, temperature, etc. are needed;
•These structures may have physical properties worth studying, such as piezoelectricity and 
photocatalytic capabilities
Motivation
•Tertiary Synthesis of nanobranches on 
secondary nano-branches of ~5 microns in 
length;
•High concentrations of the diaminoalkane, 1, 3-
propanediamine, were used in Tertiary synthesis
Synthetic Reactions  of HMT and Zn(NO3)2
• ZnO nanostructures have been extensively 
studied because of their unique properties 
including  a wide band-gap of 3.37eV1,
photocatalysis, emission and absorption of light, 
etc.
• Many ZnO nanostructures have been 
synthesized by reacting 
hexamethylenetetramine (HMT) with zinc nitrate 
in water via the mechanism shown below in 
equations (1)-(4)2.
Introduction
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Preliminary Characterization of the Binding of Peptide Derivative of an Important Ras 
GTPase Binding Effector for Abnormal Cell Signaling Mutants of the Ras Protein Cdc42
Nikita Patton, Huimin Liu PhD, Paul Adams, PhD
University of Arkansas at Fayetteville
Cell division cycle (Cdc42) is a GTPase protein in the Ras Superfamily. Ras
proteins are responsible for regulating cell growth and cytoskeleton organization 
and Ras mutants are likely to be found in many different cancer type cells. Cdc42-
GTP is the active state (GTP), Cdc42-GDP is its inactive state. When the Cdc42 
begins to act in an overactive state, this leads to cell transformation. p21 
activated kinase (PAK) is one an effector protein that interacts with Cdc42. Forty 
six amino acids of PAK known as Protein Binding Domain 46 (PBD46) interacts 
with Cdc42 to control its intake of GTP. PBD46 contains the CRIB binding domain 
which is about 12 essential amino acids that directly interact with Cdc42. When a 
mutation occurs in Cdc42 at position 28 where the phenylalanine amino acid is 
changed to leucine, the GTP/GDP cycle is more rapid which leads to cell 
transformation. This leads to cancer. This mutation is known as F28L. The 
structure of F28L is known but its binding complex is not.  Another mutation is 
referred to as ∆L8. This mutation is when the Rho insert region, amino acids 120 
to 133, have been deleted from the protein‘s amino acid sequence. ∆L8 still 
allows spontaneous GTP/GDP exchange of the protein, but does not result in 
cellular transformation. Currently, the structure and function of ∆L8 is unknown.
NSF-CHE/REU-0726004
Paul Adams, PhD
Huimin Liu, PhD
Jeremy Durchman
•Optimize the expression of mutants.
•Quantify the binding parameters of
PBD46 to each Cdc42 mutant
compared to the wildtype.
INTRODUCTION METHODS RESULTS
CONCLUSIONS
ACKNOWLEDGEMENTS 
Protein Expression
•Start overnight culture in an incubator at 37˚C. 
•Inoculate 1% of overnight culture in LB media. 
•Cell growth and cell density (Optical Density) was checked using a UV 
spectroscopy at 600nm, reading between 0.6-0.8. 
•Induce with 1mM IPTG 
•Harvest was done with centrifuge.
•Expression was confirmed  by Western Blot (WB).
In Vitro Binding Assay
The purpose of this is to determine if Cdc42 mutants F28L and ∆L8 bind 
to PBD46 relative to Cdc42 WT.
•The cell lysate of Cdc42 WT, F28L, and ∆L8 were each tested binding to 
purified PBD46. 
•GST was used as nonspecific binding controls with Cdc42 WT, F28L, and 
∆L8. 
•Mix samples in PBS buffer and 0.5mM GMPPCP was applied. 
•Incubated at 4°C  for 4 hrs. 
•Add glutathione sepharose beads and incubate at 4°C for 1hr .
•Beads were washed with PBS buffer
•Elute with 20mM Tris 10mM glutathione buffer pH8.
•Run SDS-PAGE to visualize the quantity of PBD46  and GST being 
recovered from the process.
•Perform WB. Detect Cdc42 WT and mutants by adding the first 
antibody N-terminus-His tag that binds to the His-tag and the 
secondary antibody goat anti-mouse IgG-AP. 
•Develop membrane using the enzymatic reaction of BCIP and NBT in 
TBS-MgCl2 buffer. 10% Acetic acid was used to stop the reaction once 
all the protein is visible on membrane.   
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FUTURE WORK
The In Vitro Binding assay showed
qualitative data that Cdc42 WT and
mutants does bind to PBD46 and not
GST tag.
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•Figure 1 part A shows good expression levels of the Cdc42 WT and mutants. 
•Figure 1 part B shows that expression of a protein is very sensitive to initiation 
of induction. If exponential growth is very high, then the protein expression is 
lower.
•Figure 2 verifies which bands on the gel were our proteins of interest.
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Figure 3 shows that in the In vitro binding 
assay, Cdc42 WT and mutants does bind to 
PBD46 and not GST tag.
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Analysis of Methionine Sulfoxide from Urinary Proteins in Relation to Tobacco Use
Ashley Ramsey*, Dr. Jeff Froude, and Dr. Wesley Stites
Department of Chemistry and Biochemistry
University of Arkansas, Fayetteville, AR 72701 
Introduction
Proteins are sensitive to oxidative damage and 
the biological effects are usually very important.  
Protein oxidation is proposed to contribute to 
the aging process because they are found to be 
increased in older organisms. Methionine is one 
of the easiest residues to oxidize even though it 
is not very common. The oxidation of 
methionine occurs in a wide variety of proteins. 
The oxidants found in biological systems, ozone, 
and cigarette smoke all have been shown to 
oxidize methionine in proteins and peptides. This 
oxidation tends to lower or even stop the 
biological activity.
Oxidative stress in general is linked to the 
increased tendency to coagulate, although the 
molecular mechanism is not yet completely clear. 
The blood of smokers is much more prone to 
clot than that of non-smokers.  Cardiovascular 
diseases are the most common cause of 
premature death in smokers. The most common 
cardiovascular diseases in smokers are the 
thrombotic arterial occlusive diseases, in 
particular myocardial infarction (heart attack) 
and stroke.
Purpose
To determine an analytical method to measure 
the amount of methionine sulfoxide in complex 
protein mixtures such as urine and liver. 
Methods
The procedure was the same for the urine and 
the rat liver. The only difference is that the urine 
started with spinning down in a centrifuge. The 
pellet was then re-suspended in methanesulfonic 
acid (MSA) and put into a hydrolysis tube. For 
the rat liver, the liver was thawed and weighed 
out. It was then put into a hydrolysis tube with 
MSA and a freeze-pump-thaw method was used 
to remove the gasses. The tube was then put 
into a heat block for 2 hours. Afterwards, the 
sample was diluted with water and ran through 
an ion exchange column. Five micro liters of the 
eluted sample was lyophilized dried, derivatized, 
and reconstituted in a diluent. This was then 
analyzed in the HPLC.   
These chromatograms represent how the 
peaks were determined. The samples 
were spiked with the amino acid of choice 
and analyzed in the HPLC. 
These chromatograms are of samples from a rat liver. The first shows the control, then a sample that was taken 2 hours after an 
injection of acetaminophen, and then 4 hours after the injection. The second chromatogram shows that the amount of methionine
sulfoxide increases in the liver after 2 hours and even more after 4 hours. The last chromatogram shows that the amount of methionine 
in the samples.
For the graphs, a ratio was taken for the peak of interest against a peak that was an internal standard. The levels the methionine 
sulfoxide were higher in the 2 hour and 4 hour than in the control. The level of methionine was close in the 2 hour and lower in the 4 
hour. The last graph shows that the relative amount of methionine sulfoxide was higher than the methionine in the 2 hour and 4 hour 
than in the control.
Summary
A method was determined to measure the amount 
of methionine sulfoxide in urine and liver. 
In the rat liver, the amount of methionine sulfoxide 
is being increased as the time is passed after the 
overdose of acetaminophen. We know that the peak 
is methionine sulfoxide but we are not sure if 
something else is there also. If it is something else 
with the methionine sulfoxide, the increase in 
acetaminophen is affecting it. Future tests will be 
done to determine what else is there.
In the urine studies, the amount of methionine 
sulfoxide is noticeably more in the smokers than in 
the non smokers.(results not shown) This is what 
we were expecting to find. One thing that is not as 
we expected, is the fact that the amount of 
methionine is not decreasing proportionately with 
the increase of methionine sulfoxide. We have not 
yet figured out how this is possible. These results 
show us a general increase in methionine sulfoxide 
in our test cases.
Future Work 
In the future, the Stites Research group will be 
continuing this work on both the rat livers and the 
urine. They are working on the oxidation of 
thrombomodulin and a method to measure it more 
quickly. They are also interested in using the 
method determined here and taking it further to 
increase the productivity. The group will also be 
testing this method on a number of smokers and 
nonsmokers urine samples to get more conclusive 
results. Once we know how oxidative stress effects 
the body, researchers will be able to design drugs 
that will help reduce the stress or maybe even 
prevent it.  
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Analysis of Dissolved Oxygen (DO)
Conclusions
•Eugenol can be electropolymerized onto 
a gold electrode evenly after a RCA-1 
cleaning.
•A uniform eugenol coating is 
impermeable to large molecules such as 
RuHex.
•Eugenol produces a linear DO calibration 
curve from 0.2 to 6.0 mg/L.
•The DO calibration curve using Nafion® is 
non-linear above 2.0 mg/L.
•Eugenol is a better polymer for coating 
electrodes because it electropolymerizes 
only on the gold surface, eliminating 
oxygen “trapped” in the membrane.
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Data and Results
Dissolved Oxygen Calibration Curves
Data indicates that at 14 s the 
calibration curve using 
Nafion® is non-linear, while 
eugenol is linear.  
Oxygen once “trapped” in the 
Nafion® membrane is able to 
diffuse to the electrode.
Higher DO concentrations 
and shorter times enhance 
the effect of the “trapped” 
oxygen.
Purpose
•Determine if eugenol can 
be electropolymerized on 
gold to form an even 
coating.
•Compare the performance 
of polyeugenol coating to 
that of Nafion®.
Structure of Eugenol
RCA-1 Cleaning2
•27% ammonium hydroxide, 30% hydrogen 
peroxide, and water.
•Cleaned electrode at 70°C for 15 min., then 
rinsed with water and air-dried.
Polyeugenol Formation3
•2 mm gold disk electrodes.
•10 mM eugenol in 0.10 M NaOH.
•Cyclic voltammetry (CV), 20 cycles 
between 0.7 V and 0.0 V vs. SCE at 0.1 V/s.
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Introduction
•Brain tissue oxygen monitoring is an 
important area of research.
•A major problem with electrochemical 
detection in vivo is chemical fouling due to 
cerebrospinal fluid.1
•Nafion® is an oxygen-permeable polymer 
commonly used to coat electrodes to 
prevent fouling.
•The Nafion® polymer coating is easy to 
apply, but covers the entire electrode and 
creates a “trapped” oxygen effect. 
•In this work, the performance of an 
electropolymerized eugenol film will be 
compared to Nafion® for oxygen detection.
If prepared correctly, eugenol 
films were impervious to large 
molecules.
Development of Polyeugenol Coated Electrodes for Chemical Sensors
Michelle Reed* and Dr. David Paul
Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville AR, 72701
Electrode Coating
Trapped 
O2
O2 O2
Endogenous O2 Endogenous
Nafion® Coating Polyeugenol Coating
•Cyclic voltammetry from 0.2 to 
-0.5 V vs SCE at 0.02 V/s.
•10 mM ruthenium(III) hexamine 
(RuHex) in 0.1 M KCl.
Exclusion of RuHex by Electropolymerized Eugenol
•Chronoamperometry from 0.0 V 
to -1.0 V step vs SCE; 15 s pulse 
width. 
•Various dissolved oxygen 
concentrations in 0.1 M KCl.
•Eugenol-coated electrodes (at 
left) and Nafion-coated electrodes 
(not shown).
•Current measured at 14 s after 
step.
6 µm Nafion
Eugenol
0.25 mg/L
1.00 mg/L
2.00 mg/L
3.00 mg/L
4.13 mg/L
5.00 mg/L
6.00 mg/L
6.30 mg/L
Electrode insulator
Gold Surface
Analysis of Plasma  Polymerized  Acetylene Films on Silicon Chips by Fourier Transform Mass Spectrometry  
Scott A. Robotham1,3, Saša M. Miladinović1, Valérie De Vriendt2, Stéphane Lucas2, and Charles L. Wilkins1
1University of Arkansas, Fayetteville, AR, 72701; 2University of Namur-FUNDP, Namur, Belgium; 3Nebraska Wesleyan University, Lincoln, NE, 68504
Fourier transform mass spectrometry has been 
used to identify the products formed by plasma 
polymerization of acetylene on silicon chips. 
Three chips are analyzed here. Each chip was 
formed using a different discharge method, one 
with unipolar, one with bipolar, and the last one 
with continuous discharge. Both positive and 
negative laser desorption/ionization-Fourier 
transform mass spectrometry spectra were 
collected. The analysis indicates a difference in 
the acetylene products of each film.  
Introduction 
- External source 9.4 Tesla FTMS IonSpec
- Nd:YAG laser operating at 355 nm
- Samples were placed neat on a stainless steel
target plate
Experimental
Results
The results of this analysis show the presence of carbon clusters and hydrocarbon oligomers in different relative abundances. It is
clear from the spectra that the bipolar method of plasma polymerization forms relatively more hydrocarbon oligomers compared to
the products of unipolar and continuous discharge. It can also be seen that if the thickness of the film is increased, this leads to a
broader mass range in the spectrum.
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Results Continued
LDI-FTMS of Unipolar Discharge Film LDI-FTMS of Bipolar Discharge Film LDI-FTMS of Continuous Discharge Film
Figure 1: Film Assignments Figure 2.LDI-FTMS spectra of Unipolar Discharge Film: Insets show 
partial spectrum with assignments of the most abundant peaks 
inclding calculated molecular weights and average resolving power. 
Figure 3. LDI-FTMS spectra of Bipolar Discharge Film: Insets show 
partial spectrum  with assignments of the most abundant peaks 
including calculated molecular weights and average resolving power. 
Figure 4. LDI-FTMS spectra of Continuous Discharge Film: Insets 
show partial spectrum with assignments of the most abundant peaks 
including calculated molecular weights and average resolving power 
Figure 1. Plots of  number of hydrogen versus number of carbons in 
hydrocarbon oligomers. Spectra that produced only carbon clusters 
are not plotted.  
Racemization of Chiral Lithium Carbanions:  An Exercise in 
Organic Synthesis, Analytical Chemistry, 
Solution Kinetics, and Chemical Thermodynamics
Andrew L. Ward, Department of Chemistry and Biochemistry, University of Detroit Mercy, 
4001 West McNichols Road, Detroit, MI 48221-3038,
wardan@students.udmercy.edu
Background
Conclusion
Acknowledgements
The synthesis of natural products and 
pharmaceuticals involves the use of chiral lithium 
carbanions since they can be generated using chiral 
bases and retain their structural integrity even at low 
temperatures.  When the lithium carbanion is quenched 
with an electrophile, a new chiral center can be generated.  
The main goal of our project is to determine the rate at 
which the chiral carbanion 2-Li-N-Boc-piperidine (2) 
racemizes, both in the presence and absence of diamine 
ligands.  The carbanion is synthesized by Sn/Li exchange 
from the stannane (1).
Fig. 1.  Sn/Li exchange with complexation of ligand to the racemic 
organolithium.
Synthesis
Fig. 2.  Synthesis of N-Boc-Piperidine
(5)                                                  (6)
Fig. 3.  Synthesis of 2-(tributylstannyl)-N-Boc-piperidine (1)
(6)                                            (2)                                                       (1)
Fig. 4.  Synthesis of 2-(trimethylsilyl)-N-Boc-piperidine (7)
(6)                                            (2)                                                            (7)
Fig. 5.  Synthesis of (S,S)-Pro-prolinol (10)
(8)                                (9)                                                                   (10)
Analytical Techniques
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and D. Leonori for kinetics/thermodynamics data.
1. Chromatography
Prior to studying the kinetics of racemization, it is important to be able to separate the two 
enantiomers of the silane (7).  The traditional way to do this is by Chiral Stationary Phase - Gas 
Chromatography [CSP-GC].  A representative CSP-GC chromatogram is shown below in Fig. 6. 
Fig. 6.  CSP-GC Chromatogram of Racemic Silane (7)
The disadvantages of this technique are:
1. The very long retention times [ca. 2 hours]
2. The need for sample workup to remove tetrabutyltin prior to injection [Fig. 1].
The above problems can be solved using Chiral Stationary Phase - Supercritical Fluid 
Chromatogrpahy [CSP-SFC].  Both the stannane (1) and the silane (7) can be resolved with this 
method.  A typical CSP-SFC is shown below in Fig. 7.  
(7)                                                                        (1)
Fig. 7.  CSP-SFC Chromatogram of Racemic Silane (7) and its parent
Stannane (1).
Note that the stannane (1) elutes first even though it has a higher molecular weight.  This is 
because it is the less polar of the two compounds and the column is polar.  The chiral stationary 
phase is 4-(3,5-dinitrobenzamido)tetrahydrophenanthrene covalently bonded to silica.  
2. 119Sn NMR Spectroscopy
It is clear from Fig. 1 that complete Sn/Li exchange is an essential prerequisite to any study of 
the kinetics of racemization.  The Sn/Li exchange of Fig. 1 can be readily followed in situ by 119Sn 
NMR spectroscopy, as shown below in Fig. 8.
(1)                 Bu4Sn      (1)                         Bu4Sn      (1)                         Bu4Sn      (1)
t =                        0                           30 min                                  1 hr                  4hr
Fig. 8.   Kinetic Study of the Sn/Li exchange of Fig. 1 by 119Sn NMR at -60 °C. 
(i-Pr)4Sn as internal standard (at 0 ppm).
Note how broad the Sn signal for the stannane (1) is: this is due to restricted rotation about the N-C
bond of the carbamate group at the low temperature of the reaction.
Kinetics and Thermodynamics
To date, the racemization of Fig. 1 has only been studied with TMEDA as shown 
below in Fig. 9,  at three different temperatures.  
Fig. 9.  First order plot for the racemization (2)S --> 2(R) in the
presence of one equivalent of TMEDA.
The rate constants were obtained from the slope of the line at each temperature, 
and are tabulated below.  
In order to obtain the thermodynamic activation parameters (∆H‡ and ∆S‡ ) we 
need to plot lnk vs. 1/T, where T is the absolute temperature in Kelvin.  The result 
is known as an Eyring plot.
Fig. 10.  Eyring plot of lnk vs. 1/T for the racemization of Fig. 1 in the presence of TMEDA.
The Enthalpy of Activation (∆H‡ ) for the reaction is obtained from the slope of 
the line in the Eyring plot, and the Entropy of Activation (∆S‡) come from the 
intercept on the y-axis.  The corresponding values are given below:   
∆H‡  =  19.6 ± 1.4 kcal/mol
∆S‡   =  11.5 ± 6.0 cal/mol*K 
Conclusion
The above values are surprisingly low!  They afford a reaction barrier of ca. 17 
kcal/mol over the temperature range of Fig. 9; this is 2 kcal/mol lower than the 
corresponding barrier for N-Boc-pyrrolidine in the presence of TMEDA.  It is not 
at all clear why this should be the case. 
y = -0.0001x + 2.0742
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k (s-1) -0.0001 -0.0005 -0.0042
ln(k/T) -14.6175 -13.0519 -10.9657
1/T (s-1) 0.004484 0.004292 0.004115
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0
0.00405 0.0041 0.00415 0.0042 0.00425 0.0043 0.00435 0.0044 0.00445 0.0045 0.00455
1/T
Next Steps
We are now continuing our studies of the above racemization kinetics, but in 
the presence of chiral diamine ligands.  The overall objective is to map out 
what structural features of both the carbanion and the ligand are necessary 
for the most effective dynamic thermodynamic resolution [DTR].
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